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ABSTRACT
MOLECULAR CHARACTERIZATION OF THE PATHOPHYSIOLOGY OF THE DIGITAL LAMINAE IN
ACUTE CARBOHYDRATE-INDUCED EQUINE LAMINITIS
SEPTEMBER 2013
ERICA A. PAWLAK, B.S., MICHIGAN STATE UNIVERSITY
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Samuel J. Black

Equine laminitis is a devastating condition that results in the failure of the tissue
responsible for suspending the skeleton within the hoof capsule. The digital laminae is
composed of two interdigitated layers, the dermal lamellae surrounding the distal pedal bone,
and the epidermal lamellae, which interfaces with the hoof wall. During laminitis, these layers
separate, allowing for rotation and sinking of the pedal bone. While there are multiple diseases
and physiological conditions associated with the development of laminitis, including sepsis,
metabolic syndrome, and unequal weight bearing, the exact cause remains elusive. Prior work
by our research group identified the metalloprotease ADAMTS-4 as a potential early instigator
of disease. The data presented herein catalogs the distribution of the substrates of this enzyme,
aggrecan and versican, the ramifications of ADAMTS-4-mediated versican loss in the laminae,
and further expands into the repression of the canonical wnt signaling pathway and potential
additional metalloprotease (MMP) involvement in disease, utilizing a model of acute,
carbohydrate-induced laminitis. Additionally, samples from other models of laminitis induction
and clinical samples were screened for differential expression of relevant gene markers,
including versican, members of the canonical wnt signaling pathway, and MMP-1 and -13.
Together, these data provide a characterization of laminar pathology in the carbohydrate-
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induced model, as well as highlighting key similarities and differences amongst multiple
methods of disease development, and lay important groundwork for developing clinical
therapeutic interventions.
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CHAPTER 1
INTRODUCTION
The equine digital laminae is a complex tissue that is responsible for suspending the
axial skeleton of the horse within the hoof capsule. Laminae are composed of 500 to 600
vertical folds of keratinized epidermal tissue, the primary epidermal laminae, which are
contiguous with the inner hoof wall, and interdigitated folds of connective tissue, the primary
dermal laminae, which are contiguous with the distal phalanx (Figure 1.1). Each of these
primary projections further contains 150-200 secondary projections, known as the secondary
epidermal and dermal lamellae, respectively, which increase the surface area of the interface
between the two tissue types. These two tissues are separated by a basement membrane
which lies adjacent to the basal epithelium of the secondary epidermal lamellae1,2.
Equine laminitis is a disease that results in the structural failure of the digital laminae.
Laminitis occurs secondary to a variety of systemic pathological conditions, excess carbohydrate
consumption, sepsis, metabolic and/or endocrine dysfunction, gastrointestinal injury or
impaction, unequal weight bearing secondary to an injury to the contralateral limb, and black
walnut heartwood toxemia3. The end result of these disease processes is the separation of the
dermal and epidermal lamellae, which allows for rotation and sinking of the distal phalanx due
to increased force applied by the digital flexor tendon and the weight borne on the hoof. In
severe cases, the bone may actually penetrate the bottom of the hoof. This condition causes
crippling lameness which commonly results in humane euthanasia of the animal. The severity of
disease is measured by the Obel Scale, with a score of 1 corresponding to lameness only
discernible at the trot, and a maximum score of 4 corresponding to near total recumbence4. In
the United States, approximately 2% of the 9.2 million horses are affected by laminitis,
substantially disrupting the estimated $39 billion domestic equine industry 5. Because of an
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overall lack of understanding of the underlying pathophysiology of laminitis, the equine patient,
client, and equine veterinarian have suffered though decades of treatment failures, which has
led the USDA, the Morris Animal Foundation, and the American Association of Equine
Practitioners to deem laminitis a research priority.
Much of our knowledge on the development of laminitis is the result of studies in model
induction systems. The two models used primarily at the start of the studies included in this
dissertation were carbohydrate overload (CHO), which encompassed dosing a horse with a
starch gruel (85% corn starch and 15% wood flour suspended in water)6, and the black walnut
heartwood extract (BWE) model. BWE-induced laminitis displays rapid onset but is transient
and will spontaneously resolve. Laminar inflammation occurs within 2 hours of toxin
administration, and lameness is first noted by 10-12 hours after treatment, but animals rarely
develop laminitis past Obel Grade 1 (OG1) 7. In contrast, CHO-induction mimics accidental grain
ingestion or pasture-associated laminitis, with OG1 lameness occurring at around 24 hours post
treatment and OG3 lameness occurring at around 40 hours 6. More recently, carbohydrate
overload induction methods utilizing oligofructose (OF) 8, which more accurately mimics the
carbohydrates found in lush pasture grass, and induction with a prolonged euglycemichyperinsulinemic clamp (p-EHC)9 have been developed.
Histologic analyses of laminae from horses with experimentally-induced and naturally
acquired laminitis show several pathologic features that may contribute to their failure. These
include increased apoptosis of basal epithelial cells 10, reduced presence of hemidesmosomes in
basal epithelial cells resulting in diminished attachment to the basement membrane, and loss of
anchoring filaments that attach the basement membrane to adjacent fibrillar collagen 2 of the
secondary dermal laminae. In addition, sections of laminae from laminitic horses show
infiltration of the dermal laminae by inflammatory leukocytes11,12. Determining the enzymes
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that mediate this damage is an essential step towards identifying therapeutic inhibitors. We
and others have shown that matrix metalloproteinase-2 (MMP-2) and MMP-9 are elevated in
laminitic laminae12-17. The concentration of MMP-9 in laminitic laminae correlates directly with
the number of inflammatory leukocytes12,17 suggesting these cells are the source of the enzyme.
In contrast, the concentration of MMP-2 bears no relationship to that of inflammatory
leukocytes or MMP-918 suggesting production by a cell that is endogenous to the laminae.
MMP-9 is present in inactive zymogen form only and hence may be of little relevance to the
disease process. However, much of the MMP-2 is present as an active form, which is
significantly elevated in the laminae of horses with OG3 lameness when analyzed as a group
although some horses develop severe laminitis in the absence of elevated laminar MMP-218.
These observations indicate that MMP-2 is not the sole cause of laminar degradation.
Furthermore, more recent studies show that there is little or no MMP-2 activity present in
extracts of laminae collected from horses during the developmental and OG1 stages of lameness
(Wang and Black, unpublished), suggesting that MMP-2 may have a role at the time of
catastropic breakdown of the laminae only, or in attempts by the tissue to repair this process.
The lack of correlation between MMP-9 and MMP-2 expression and the development of
laminitis in the face of obvious ECM injury in the disease process led us to examine a broader
group of metallopoteinases and to characterize the types and distributions of the main lamellar
ECM components (collagens, laminins, proteoglycans and glycosaminoglycans). These studies
showed that expression of the gene encoding ADAMTS-4 is elevated (~100 fold) in the laminae
of horses with black walnut toxin- and starch gruel-induced laminitis and in laminae of horses
with naturally acquired disease and is not accompanied by elevated expression of genes
encoding tissue inhibitors of metalloproteinases (TIMPs) 19.
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These data led us to hypothesize that the substrates of ADAMTS-4, namely, aggrecan
and versican, were not only present in the equine digital laminae, but that loss of these
proteoglycans would be a critical pathological feature of equine laminitis. In following this
hypothesis, we have created an extensive molecular characterization of the pathogenesis of
laminitis in the CHO model system, which will be detailed in the following chapters of this
dissertation.

4

1.1 Chapter 1 Figures

Figure 1.1
Gross Anatomy of the Equine Digital Laminae (Design: Chris Pollitt, Art. John McDougall): The
Figure is reproduced by permission of Dr. C. Pollitt. Sections of laminae presented in this
dissertation are from the mid dorsal front hoof laminae and the region is delineated by the oval
shown in this figure.
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CHAPTER 2
DISTRIBUTION AND PROCESSING OF ADAMTS-4, AGGRECAN, VERSICAN, AND
HYALURONAN IN THE EQUINE DIGITAL LAMELLAE

2.1 Introduction
The equine digital laminae span between the surface of the distal phalanx and the inner
hoof wall. Laminae are composed of 500 to 600 vertical folds of keratinized epidermal tissue,
the primary epidermal laminae, which are contiguous with the inner hoof wall, and
interdigitated folds of connective tissue, the primary dermal laminae, which are contiguous with
the distal phalanx1. Each fold of primary epidermal and dermal laminae has 150 to 200
interdigitated folds of secondary laminae resulting in a greatly expanded contact area between
these tissue layers. The secondary epidermal and dermal laminae join at a basement
membrane, which is a meshwork of collagen fibers and laminins cross-linked and anchored via
hemidesmosomes to basal epithelial cells residing at the boundary of the epidermal laminae2.
The basement membrane is tethered to tensile collagen fibers of the dermal laminae, which are
bound by a variety of extracellular matrix components to each other and to integrins expressed
by cells on both sides of the membrane20, thus ensuring integrity of the two layer structure. The
basal epithelial cells, or stem cells within this population, give rise to keratinocytes which move
outward towards the hoof wall and, analogous to skin epidermal cells, increase their keratin
content, generate a cornified cell envelope and undergo terminal differentiation 21,22.
The digital laminae resist force imposed by the deep flexor tendon through the distal
phalanx to the dermal attachments to the bone23-25. They also support the vertical load of the
horse and accommodate compression and stretch deformation created by the flexing, twisting
and tilting of the hoof capsule under different loading conditions. In addition, the laminae
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absorb a portion of the concussive shock imposed when the hoof strikes a solid surface.
Concussive shock most likely dissipates in the hoof by freedom of movement of hydrated keratin
fibers within the epidermal laminae and transfer of load from the hoof wall to the dermal
connective tissue and distal phalanx through the basal epithelial cell layer. Basal epithelial cells
are therefore subjected to biomechanical stress and concussion waves of varying amplitude and
frequency.
Analyses in model systems show that cells adapt to constant and discontinuous
mechanical stress through mechanoreceptor signaling26,27. In this regard, chondrocyte explants
that are subjected to dynamic compression within a tolerable range respond by elevated
extracellular matrix production26 including elevated production of large polysulfated
proteoglycans. Since the equine digital laminae are also subject to dynamic
compression/stretching they may also have a highly specialized extracellular matrix that is rich
in polysulfated proteoglycans. Indeed, the gene encoding ADAMTS-4, which is a secreted
enzyme that regulates turnover of large polysulfated proteoglycans in the extracellular matrix, is
expressed in laminae of healthy horses 28, which suggests that its substrates may also be present
in the tissue.
The main substrates of ADAMTS-4 in peripheral tissues are aggrecan and versican29.
These proteoglycans have glycosaminoglycan attachment domains that can be heavily
substituted with chondroitin sulfate side chains, and, in the case of aggrecan, also keratan
sulfate side chains30-32. Both aggrecan and versican have a hyaluronan binding site in the N
terminal G1 domain, which facilitates assembly of massive and highly charged macromolecular
complexes in the extracellular matrix. The anionic groups on the glycosaminoglycans carry with
them positively charged counter ions, such as Na+, creating an osmotic gradient and drawing
water into the tissue. The resulting hydrated gel protects tissue from compression
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deformation30,33,34. Given that laminae express the gene encoding ADAMTS-4 and are subjected
to biomechanical and concussion stress, it was of interest to determine expression and
localization patterns of ADAMTS-4 and its proteoglycan substrates in the laminae. Here we
report that ADAMTS-4 and its substrates are indeed present in healthy laminae, but,
unexpectedly, localize within basal epithelial cells of the secondary epidermal laminae rather
than in the extracellular matrix.

2.2 Results
2.2.1

Gene Expression
Genes encoding ADAMTS-4, aggrecan, versican and hyaluronan synthase II are

expressed in the equine digital laminae of 8 healthy horses as determined by RT-qPCR. Primer
sets are described in table 1 and each generated a single product of expected size (Appendix B,
representative results are shown in Fig 2.1; Lane 2 aggrecan; Lane 3 versican; Lane 4 hyaluronan
synthase II; Lane 5 ADAMTS-4 N terminal domain; Lane 6 ADAMTS-4 C-terminal domain; Lane 7
GAPDH; Lane 8 blank control) and sequence (data not shown). Mean Ct values +/- 1 standard
deviation were: GAPDH 21.82+/- 0.88, aggrecan 29.02+/-1.37, versican 25.84+/- 1.20,
hyaluronan synthase II 30.34 +/- 0.94, ADAMTS-4 (N-terminal domain primers) 34.12 +/- 1.57,
ADAMTS-4 (C-terminal domain primers) 32.45 +/- 1.054. No Ct value was recorded for the blank
control.
Versican is composed of 4 domains, namely an N terminal G1 domain, which has the
hyaluronan binding site, a αGAG domain which has sites for attachment of chondroitin sulfate
side chains, a βGAG domain which also has sites for attachment of chondroitin sulfate side
chains and a lectin like C terminal domain, which has 2 epidermal growth factor-like motifs35.
Four splice variants (isoforms) of versican are made comprising the V0 isoform which has all 4
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domains ordered as above; the V1 isoform which has G1, βGAG and C domains only; the V2
isoform which has G1, α GAG and C domains only; and the V3 isoform which has G1 and C
domains only and therefore lacks glycosaminoglycans 36. Comparative RT-qPCR analyses
performed with primer sets specific for equine versican G1, αGAG, βGAG and C terminal
domains showed ratios close to 1:1:1:1 (data not shown) consistent with expression of the full
length gene. In addition, RT-PCR analyses performed with primer sets specific for equine V0
versican - αGAG/βGAG (Fig 2.2, lane 2), V1 versican - G1/βGAG (Fig 2.2, lane 3), V2 versican G1/αGAG (Fig 2.2, lane 4), and V3 versican - G1/C (Fig 2.2, lane 5) showed that spliced sequence
encoding V0 and V1 versican isoforms were abundantly present in laminae while those encoding
the V2 isoform were less abundant and spliced sequence encoding the V3 isoform were not
detected. Primer specificity was confirmed by sequencing the products (not shown).

2.2.2

Protein Expression

Extracts from the 8 laminae were subjected to Western blotting following SDS-PAGE
(Appendix A) to determine the protein expression of ADAMTS-4 and its substrates.
Representative results are presented in Figure 2.3.

2.2.2.1 ADAMTS-4
Proteins in NP-40 extract of laminae were subjected to SDS-PAGE and ADAMTS-4 was
detected by Western blotting using an antibody specific for the catalytic site cleavage
neoepitope FASLSRFVET which is revealed only upon removal of the regulatory propeptide37.
Results are presented in Figure 2.3A and show that processed ADAMTS-4 is predominantly
present as a ~51 kDa polypeptide accompanied by a ~41 kDa form. The ~51 kDa polypeptide
was detected in all 8 laminae extracts analyzed, while the ~41 kDa polypeptide was detected in
only 6 of 8 laminae extracts analyzed. The same results were obtained when samples of
9

pulverized laminae were directly solubilized in SDS-sample buffer (data not shown) showing that
processing of ADAMTS-4 by propeptide convertase38,39, which exposes the FASLSRFVET catalytic
site neoepitope, was not an extraction artifact.

2.2.2.2 VO/V1 Versican
To explore versican protein expression, NP-40 laminae extracts of laminae were subjected
to SDS-PAGE and ADAMTS-4 V0/V1 versican cleavage fragments were revealed by Western
blotting using an antibody specific for the C terminal V0/V1 versican β GAG domain neoepitope
DPEAAE. Results are presented in Figure 2.3B and show V0/V1 versican fragments of ~109 kDa
and ~66kDa. Detection of the polypeptides was abrogated when anti-DPEAAE antibodies were
pre-incubated with sense peptide but not antisense peptide (data not shown). The ~109 kDa
polypeptide was detected in 6 of 8 laminae extracts analyzed, while the ~66kDa polypeptide was
detected in all 8 laminae extracts analyzed. Polypeptide bands of similar size were detected
when pulverized laminae was directly solubilized in SDS-sample buffer (data not shown)
showing that processing of V0/V1 versican by ADAMTS-4 was not an extraction artifact.

2.2.2.3 V0/V2 Versican
NP-40 laminae extracts were subjected to SDS-PAGE and ADAMTS-4 V0/V2 versican
cleavage fragments revealed by Western blotting using an antibody specific for the C terminal
V0/V2 versican α GAG neoepitope NIVSFE . Results are presented in Figure 2.3C and show
V0/V2 versican fragments of ~112 kDa and ~68 kDa. The polypeptides were detected in all 8
laminae extracts analyzed and detection of bands was abrogated when antibodies were preincubated with sense peptide but not antisense peptide (data not shown). Polypeptide bands of
similar size were detected when tissue was directly solubilized in SDS-sample buffer (data not
shown) showing that processing of V0/V2 versican by ADAMTS-4 was not an extraction artifact.
10

2.2.2.4 Aggrecan
SDS-PAGE analysis of ADAMTS-4 fragments of aggrecan required their extraction from
pulverized laminae by guanidine hydrochloride buffer, precipitation with ethanol and
subsequent digestion with hyaluronidase, chondroitinase ABC and keratanase (data not shown).
These treatments were necessary because aggrecan ADAMTS-4 cleavage fragments: i) were not
extracted from pulverized laminae by incubation with NP-40 buffer, ii) co-extracted with their
binding partner hyaluronan in guanidine hydrochloride buffer, and were held in an insoluble
hyaluronan gel upon replacement of guanidine hydrochloride with water or physiological buffer,
iii) were heavily glycosylated, particularly with chondroitin sulfate glycosaminoglycans, which
prevented migration through the stacking gel in SDS-PAGE in the absence of appropriate
digestion. Western blotting performed following SDS-PAGE of the hyaluronidase,
chondroitinase ABC and keratanase digested guanidine hydrochloride extracted material using
an antibody specific for the aggrecan N terminal ADAMTS-4 cleavage neoepitope ARGSVIL
revealed bands at ~318 kDa, ~250 kDa, ~150 kDa and ~70 kDa (a representative result is shown
in Fig 2.3D). These polypeptide bands were detected in the 8 laminae extracts analyzed.

2.2.3

Immunohistological evaluation

To determine the cellular localization of ADAMTS-4 and its substrates, immunohistological
studies were performed on flash frozen OCT-embedded laminae (n=6). All samples were
analyzed for each staining protocol and representative results are shown below.

2.2.3.1 General Structure
A thin transverse section of frozen digital laminae stained with a pan-laminin specific
antibody revealed by a texas red-conjugated secondary antibody (red), and with the DNA
intercalating dye DAPI (blue), is shown in Figure 2.4 A. Laminin is a component of the basement
11

membrane which lies at the junction between the secondary epidermal and dermal laminae.
Laminin is also a component of the basement membrane of small blood vessels which can be
seen as small red open circles in the secondary dermal laminae, and of blood vessels in the
primary dermal laminae. DAPI (blue) stained cell nuclei can be seen throughout the tissue and
those of the basal epithelial cells abutting the basement membrane. Some tissue components,
putatively collagen fibers in primary and secondary dermal laminae, autofluoresce green at the
excitation wavelength (488nm) used in the studies (Fig 2.4A). This autofluorescent material can
also be seen in Figures 2.5A, 2.5B, Figure 2.6A and Figure 2.7A, has a relatively weak signal
which is not digitally recorded when a bright green fluorescent signal is obtained following
appropriate specific staining, e.g., after staining thin frozen sections with FITC-phalloidin as
shown in Figure 4B and discussed below.
Additionally, a section of frozen digital laminae stained with FITC-phalloidin (green) to
detect actin bundles and DAPI (blue) to detect DNA in nuclei is shown in Figure 2.4B. The FITCphalloidin is most densely associated with the cortical actin skeleton of basal epithelial cells (the
outermost cell layer of the secondary epidermal laminae; Fig 2.4B), but can also be seen defining
the cortical actin skeleton of suprabasal cells extending into the primary epidermal laminae (Fig
2.4B). Note that DAPI (blue) stained nuclei are faded or absent from keratinocytes in the
primary epidermal laminae. The contiguous keratinocyte cortical actin network evident
throughout the secondary epidermal laminae indicates that there is little room for extracellular
matrix in this tissue. The phalloidin-FITC stain is bright and very little exposure time was
required to capture the image shown in Figure 2.4B, accounting for the almost complete
absence in the captured image of the green autofluorescent materials seen in Fig 2.4A.
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2.2.3.2 Versican
A thin transverse section of frozen digital laminae stained with antibody specific for the
carboxy-terminal domain of all versican isoforms revealed with a secondary antibody
conjugated with a proprietary red dye, and with the DNA intercalating dye DAPI (blue), is shown
in Figure 2.5A. It is notable that versican staining is restricted to a single layer of cells, putatively
the basal epithelial cells. Specific staining of versican was inhibited by pre-incubation of the
antibody with its competing peptide (Fig 2.5B) but not with an antisense peptide (not shown).
Identification of the versican-stained (red) cell layer as basal epithelial cells was confirmed by
showing that the cells are adjacent to the basement membrane. This was achieved by staining a
thin section of frozen laminae with: i) pan-anti-laminin antibody revealed here by a secondary
antibody conjugated with a proprietary green fluorescent dye, ii) anti-versican antibody
revealed by red fluorescent dye -conjugated secondary antibody and iii) with DAPI which stains
nuclei blue. Results are presented in Figure 2.5C. The versican (red) does not actually contact
(co-localize with) basement membrane laminin (green), which would have given a yellow
merged image. To test whether versican is contained with basal epithelial cells, a thin
cryosection was co-stained with anti-versican antibody which was detected using a texas redconjugated secondary antibody (red) and the section was also stained with FITC-phalloidin to
detect actin bundles (green) and with DAPI (blue) to detect cell nuclei. Results presented in
Figure 2.5D show that versican (red) is located between the cortical actin of basal epithelial cells
(green) and the cell nuclei (blue). In addition, it is clear that versican staining is not pronounced
along cell boundaries suggesting little or no accumulation of the proteoglycan in extracellular
space.
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2.2.3.3 Aggrecan
A representative thin transverse section of frozen digital laminae was stained with antibody
that reacted with an epitope on the G2 domain of aggrecan revealed with a proprietary red
fluorescent dye-conjugated secondary antibody, and co-stained with DAPI (blue) (Figure 2.6A).
Aggrecan staining (red) was greatest in basal epithelial cells but was also detected in regions of
the epidermal laminae occupied by supra-basal epithelial cells. Aggrecan was largely, if not
entirely, absent from primary and secondary dermal laminae. Autofluorescent material
(putatively collagen; green) is readily seen in this image. Aggrecan staining was inhibited by preincubation of the antibody with its competing peptide (Fig 2.6, inset B). To further identify the
distribution of aggrecan in laminae, a transverse thin frozen section was co-stained with
aggrecan specific antibody (red), FITC-phalloidin (green) to detect actin bundles and DAPI (blue)
to detect nuclei. Aggrecan staining (red) was present within punctuate bodies contained within
boundaries defined by phalloidin stained cortical actin (green) (Fig 2.6, inset C). A similar tissue
distribution was seen in immunohistological sections stained with the antibody against the
“ARGSVIL” epitope of aggrecan (data not shown).

2.2.3.4 Hyaluronan
A representative thin transverse section of frozen digital laminae was stained with antibody
specific for hyaluronan polysaccharide revealed with texas red-conjugated secondary antibody
(red), and co-stained with DAPI (blue). Results are shown in Figure 2.7A which shows that
hyaluronan (red) is diffusely present in the epidermal laminae and is not pronounced along cell
boundaries (Fig 2.7A). Staining was absent from tissue sections that had been pre-treated with
hyaluronidase (Fig 2.7, inset B). Hyaluronan staining within the secondary epidermal laminae

14

was contained within cell boundaries defined by phalloidin stained cortical actin (green) (Fig 2.7
inset C).

2.2.3.5 ADAMTS-4
Thin transverse sections of frozen digital laminae were stained with an antibody specific to
the peptide “NTPEDSDPDHFD” corresponding to amino acids 300-311 of the metalloprotease
domain of equine ADAMTS-4. ADAMTS-4 staining was revealed with a red fluorescent dyeconjugated secondary antibody and nuclei counterstained with DAPI (blue). Antibody specificity
was confirmed by western blotting, which revealed similar band patterns to those obtained
using the “FASLSRFVET” ADAMTS-4 antibody (shown in Fig 2.3A) and by inhibition of Western
blotting with sense but not antisense peptide (data not shown).
Staining was diffusely present throughout the epithelial cells of the secondary epidermal
lamellae (Figs 2.8A and B), and was abrogated by pre-incubation of the antibody with its
immunizing peptide (Fig 2.8A, inset) but not with a non-competing peptide (data not shown).
Punctate staining was also present in cells associated with the vasculature (Fig 2.8A, white
arrow), mononuclear cells of the dermal lamellae (Figs 2.8A and B, blue arrows), and dermal
fibroblasts (Fig 2.8B, yellow arrows).

2.3 Discussion
Using RT-qPCR and validated primers we show that equine digital laminae express genes
encoding ADAMTS-4, aggrecan, versican (processed to V0, V1 and V2 splice isoforms) and
hyaluronan synthase II. Using SDS-PAGE followed by Western blotting with antibodies specific
for conserved peptides in horse and human ADAMTS-4, aggrecan and versican, and validated by
peptide competition, we confirmed that gene expression is accompanied by protein expression
and that the core proteins of the large polysulfated proteoglycans are subject to constitutive
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ADAMTS-4 cleavage in vivo. Using immunofluorescent and immunohistochemical staining of thin
sections of laminae with specific antibodies validated by peptide competition or targeted
epitope digestion, we show that aggrecan, versican and hyaluronan are predominantly present
within basal epithelial cells of the secondary epidermal laminae, while ADAMTS-4 is present
within these cells and also in cells of the dermal laminae.
In all laminar extracts, ADAMTS-4 was present predominantly as a ~51 kDa form bearing
the conserved FASLSRFVET neoepitope, which is exposed upon removal of regulatory
propeptide by furin propeptide convertase in the trans golgi 38. A minor ~61 kDa form bearing
the neoepitope was also detected in all samples but staining was too weak to be visible in the
images presented. In addition, a ~42kDa form of ADAMTS-4 bearing the FASLSRFVET
neoepitope was detected in extracts from 75% of samples tested. Processed ADAMTS-4 bearing
the FASLSRFVET neoepitope has a MW between ~68 kDa and 70 kDa in mice and humans and a
portion of the material undergoes autoproteolysis to generate ~61 kDa, 51 kDa and 40 kDa
polypeptides34,40,41 corresponding to the ~61 kDa, ~51 kDa, ~42 kDa laminae material reported
here. The absence of the ~68 kDa– 70 kDa enzyme from extracts of laminae suggests that
autoproteolytic activity of equine ADAMTS-4 may be greater than that of murine and human
ADAMTS-4.
In addition to cleaving the large polysulfated proteoglycans, autoproteolysed ADAMTS-4
has been shown to cleave low molecular weight leucine rich proteoglycans which bind collagens
and fibronectin, affecting fiber formation and network organization 41,42. Thus, in the equine
digital laminae, ADAMTS-4 may cause the re-organization of a broad range of ECM components.
This increased cleavage capability may have implications for the development of laminitis.
Aggrecan is a highly glycosylated multidomain protein33. The core protein of ~220 kDa can be
decorated with up to 100 chondroitin sulfate side chains each of ~20 kDa positioned between
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globular domains 2 and 3. Aggrecan can also be decorated with up to 60 keratin sulfate side
chains each of ~5 kDa to ~15 kDa which are more widely distributed on the molecule than the
chondroitin sulfate glycosaminoglycans. In addition, a variable number of O- and N-linked
oligosaccharide side chains can also be added. ADAMTS-4 cleaves aggrecan between the G1 and
G2 domains at the Glu373-Ala374 bond yielding a large glycosaminoglycan rich fragment with an N
terminal ARGSVI cleavage neoepitope and a G1 fragment with a NITEGE neoepitope. Antibodies
specific for ARGSVIL detected polypeptides of ~318 kDa, ~250 kDa, ~150 kDa and ~70 kDa,
present in guanidine hydrochloride extracts of laminae that were further subjected to
hyaluronidase/chondroitinase ABC digestion. The largest fragments most likely correspond to N
or O glycosylated material. This presence of polypeptides bearing the ADAMTS-4 cleavage
neoepitope in lamina extracts indicates that endogenous ADAMTS-4 is active in the laminae.
Cleavage of aggrecan between Glu373-Ala374 by ADAMTS-4 and ADAMTS-5 in cartilage allows
large glycosaminoglycan rich fragments, which are no longer anchored to hyaluronan, to diffuse
into synovial fluid43. However, constitutive cleavage of aggrecan in the laminae did not allow
the ARGSVI positive glycosaminoglycan-rich fragments to easily detach from the tissue, inferred
from our inability to extract the fragments into NP-40 homogenization buffer. Rather, overnight
incubation of pulverized laminae in a 4M guanidine hydrochloride extraction buffer was
required to extract the cleavage fragments suggesting that they are held in the lamellar tissue
by interactions with other as yet unidentified molecules.
NP-40 and direct SDS sample buffer extracts of pulverized laminae contain V0/V1
versican fragments of ~109 kDa and ~66 kDa bearing the C terminal β GAG domain ADAMTS-4
cleavage neoepitope DPEAAE. The MWs of these fragments are unaffected by digestion with
hyaluronidase or chondroitinase ABC and hence the fragments do not have attached hyaluronan
or chondroitin sulfate glycosaminoglycans. It is likely that the ~66 kDa fragment described here is
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equivalent to the ~70 kDA DPEAAE positive G1 domain of versican V1 reported to be present in
ADAMTS-4 treated human aorta44. The extracts of laminae also contained ~112 kDa and ~68 kDa
V0/V2 versican fragments bearing the C terminal ADAMTS-4 α GAG domain cleavage neoepitope
NIVSFE. ADAMTS-4 cleavage of fully deglycosylated human aorta V0/V2 versican has been shown
to yield an NIVSFE positive fragment of ~64 kDa which is equivalent to the glial hyaluronate
binding protein of human brain V2 versican45. Although we digested extracts of laminae with
chondroitinase ABC we did not digest with sialidase or O-glycanase perhaps accounting for the
larger sized (~68 kDa) putative versican G1- α GAG domain fragment detected in our studies. The
~112 kDa material is however too large to be comprised solely of the ADAMTS-4 cleaved versican
G1 and α GAG core protein domains, suggesting that it may be heavily N-glycosylated. The ~112
kDa and ~68 kDa polypeptides bearing the NIVSFE neoepitope were also detected (data not
shown) by antibodies raised against the N-terminal 13-residue peptide sequence of human
versican (LF-9946 , a gift from Dr. Larry Fisher, NIH) which is 87% homologous to matched equine
sequence further supporting their identify as fragments of versican.
Aggrecan and versican have been extensively studied in articular cartilage, tendons, and
atherosclerotic plaque where they associate with hyaluronan in the extracellular matrix
(ECM)29,33,47. Hyaluronan is a non-sulfated glycosaminoglycan that is synthesized at the plasma
membrane by one of three distinct hyaluronan synthases 48 and extruded into the extracellular
space. Hyaluronan synthase II, which was shown here to be expressed in the laminae, makes
the longest hyaluronan chains, which can be larger than 2000 kDa. Hyaluronan binds a large
number of aggrecan monomers with binding stabilized by link protein. These complexes can
reach several hundred millions of Daltons 30. The large negatively charged complexes of
aggrecan and hyaluronan attract and hold water in tissues, forming a hydrated gel. This is
packaged in collagen fibers in articular cartilage and tendon, accounting for the high resistance
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of these tissues to compression deformation33. Versican is also a hyaluronan-binding
proteoglycan. It is expressed in fast growing cells of many tissues including the skin, the media
of the aorta and in developing chicken limb buds 49, where it is implicated in regulating cell
proliferation and migration as well as in expanding the ECM and increasing its viscoelasticity.
Given these data, it was expected that aggrecan, versican and hyaluronan in the digital laminae
would also be associated with ECM as well as present in producer cells. However, the materials
were not observed to be present in the ECM. Furthermore the secondary epidermal laminae
had little to no discernable ECM.
Aggrecan was detected in punctuate bodies contained within cortical actin boundaries
throughout the basal and suprabasal epithelial cells of the secondary epidermal laminae.
Hyaluronan staining was also present in punctuate bodies contained within cortical actin
boundaries throughout the secondary epidermal laminae. In contrast, versican staining was
restricted to basal epithelial cells only. Versican was not detected in any suprabasal epithelial
cells in the secondary epidermal laminae. Thus, our studies suggest that versican, aggrecan and
hyaluronan may be useful markers for defining specialization within epidermal keratinocytes.
In addition to aggrecan, versican and hyaluronan, basal epithelial cells also contained ADAMTS4. Because versican fragments bearing an ADAMTS-4 neoepitope were readily extracted from
laminae into SDS sample buffer, which prevents post extraction processing, it can be concluded
that a portion if not all versican and ADAMTS-4 share an intracellular compartment that permits
ADAMTS-4 activity. Furthermore, because aggrecan fragments bearing an ADAMTS-4
neoepitope could also be extracted from laminae, it is likely that at least a portion of aggrecan
and ADAMTS-4 also share an intracellular compartment that permits ADAMTS-4 activity. Thus,
ADAMTS-4 contributes to processing, and most likely turnover of aggrecan and versican within
laminar basal epithelial cells.
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The biological roles of aggrecan, versican, hyaluronan and ADAMTS-4 in equine digital
laminae are not directly illuminated by the above studies. However, based on known
compression-resistance and cell signaling properties of the large polysulfated proteoglycans it is
reasonable to propose that the proteoglycans affect development and maintenance of the basal
epithelial cell layer, and may cushion basal epithelial cells against the severe biomechanical
stresses associated with their anatomical location.
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2.4 Chapter 2 Figures

Figure 2.1
Analysis of RT-qPCR Products for ADAMTS-4 and Substrates: Lane 1, DNA marker (100 bp
ladder); Lane 2 aggrecan; Lane 3 versican; Lane 4 hyaluronan synthase II; Lane 5 ADAMTS-4 N
terminal domain; Lane 6 ADAMTS-4 C-terminal domain; Lane 7 GAPDH; Lane 8 blank control.
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Figure 2.2
Analysis of PCR Products for Versican Isoforms: Lane 1, DNA marker (100 bp ladder); Lane 2,
V0; Lane 3, V1; Lane 4, V2; Lane 5, V3.
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Figure 2.3
Immunoreactivity of ADAMTS-4 and its Substrates: Western blots of laminar extracts (30 μg
protein/lane) were probed using: A) antibody against neoepitope FASLSRFVET exposed on
ADAMTS-4 catalytic domain after removal of the regulatory propeptide (NP-40 extract); B)
antibody against versican V0/V1 neoeptiope DPEAAE generated by ADAMTS-4 cleavage (NP-40
extract); C) antibody against versican V0/V2 neoeptiope NIVSFE generated by ADAMTS-4
cleavage (NP-40 extract); D) antibody against aggrecan neoepitope ARGSVIL (BC-3) generated by
ADAMTS-4 cleavage (guanidine hydrochloride extract digested with hyaluronidase,
chondroitinase ABC and karatinase III).
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Figure 2.4
Defining Lamellar Structure via Localization of Laminin and Actin: A) Epidermal/dermal
lamellar boundary is visualized by immunofluorescent staining against the basement membrane
marker laminin in red. Autofluorescent material (putatively collagen) in green, nuclei stained
blue; B) Epidermal cellular boundaries visualized with staining against actin in green, nuclei
stained blue. The images are representative of samples from 6 animals analyzed. Scale bars
50μm.
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Figure 2.5
Versican Localization in the Basal Epithelium of the Secondary Epidermal Lamellae: A)
Immunofluorescent staining against versican in red, autofluorescent material in green, nuclei
stained blue; B) versican staining blocked by pre-incubation of primary antibody with cognate
peptide, autofluorescent material in green, nuclei stained blue; C) versican staining in red,
basement membrane visualized by staining against laminin in green, nuclei stained blue; D)
versican staining in red, epithelial cell boundaries visualized by staining against actin in green,
nuclei stained blue. The images are representative of samples from 6 animal analyzed. Scale
bars 50μm.
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Figure 2.6
Aggrecan Localization in the Secondary Epidermal Lamellae: A) Immunofluorescent staining
against aggrecan in red, autofluorescent material in green, nuclei stained blue; B) aggrecan
staining was blocked by preincubation of the primary antibody with cognate peptide,
autofluorescent material in green, nuclei stained blue; C) aggrecan staining in red, epithelial cell
boundaries visualized by staining against actin in green, nuclei stained blue. The images are
representative of samples from 6 animals analyzed. Scale bars 50μm.
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Figure 2.7
Hyaluronan Localization in the Secondary Epidermal Lamellae: A) Immunofluorescent staining
against hyaluronan in red, autofluorescent material in green, nuclei stained blue; B) hyaluronan
staining abrogated by incubation of tissue section with epitope-digesting enzyme
(Chondroitinase ABC pH 6.8), autofluorescent material in green, nuclei stained blue; C)
hyaluronan staining in red, epithelial cell boundaries visualized by staining against actin in green,
nuclei stained blue. The images are representative of samples from 6 animals analyzed. Scale
bars 50μm.
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Figure 2.8
ADAMTS-4 Localization in the Secondary Epidermal Lamellae: A) Immunofluorescent staining against ADAMTS-4 “NTPEDSDPDHFD” epitope in
red, autofluorescent material in green, nuclei stained blue. Staining blocked by cognate peptide in inset. B) Higher magnification image,
ADAMTS-4 visualized in red, autofluorescent material in green, nuclei in blue. Images representative of samples from 6 animals analyzed. Scale
bars 50μm. White arrows indicate vascular endothelia, blue arrows indicate mononuclear cells of the dermal lamellae, yellow arrow indicates a
dermal fibroblast.
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CHAPTER 3
CLEAVAGE BY ADAMTS-4 AND GENE REPRESSION DEPLETE VERSICAN FROM THE DIGITAL
LAMINAE OF HORSES WITH STARCH GRUEL-INDUCED LAMINITIS

3.1 Introduction
Histologic analyses of laminae from laminitic horses show several pathologic features that
may contribute to their failure. These include increased apoptosis of basal epithelial cells 50,
reduced presence of hemidesmosomes in basal epithelial cells resulting in diminished
attachment to the basement membrane and loss of anchoring filaments that attach the
basement membrane to adjacent fibrillar collagen2,51. In addition, sections of laminae from
laminitic horses show infiltration of the dermal laminae by inflammatory leukocytes53,54 and
development of regions within the secondary dermal laminae that lack both cellular and
extracellular matrix (ECM) components (Pawlak and Black, unpublished, see Chapter 5)
consistent with enzymatic degradation. Identifying physiological changes in basal epithelial cells
that cause their detachment from the basement membrane or apoptosis, as well as the
enzymes that mediate damage to the basement membrane and its adjacent ECM are essential
steps towards developing effective therapies.
We and others have shown that pro-matrix metalloproteinase (MMP)-9, pro-MMP-2 and
MMP-2 are elevated in laminae of horses with naturally acquired laminitis and in some models
of experimentally induced laminitis13,15,53,55,56. Invariably, the concentration of pro-MMP-9 in the
laminae correlates with the presence and the myeloperoxidase signature of inflammatory
leukocytes53,56 whereas expression of pro-MMP-2 and MMP-2 bears no relationship to the
concentration of myeloperoxidase or to the concentration of pro-MMP-9. This suggests that the
pro-MMP-2 is produced by a cell other than an inflammatory leukocyte53. The regulatory pro-
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peptide of pro-MMP-9 typically blocks access to the active site, but conformational changes
induced by binding of pro-MMP-9 to substrate, or by oxidative modification of pro-MMP-9, can
permit catalytic activity without proteolytic removal of the pro-peptide57,58. However, although
there is evidence of lipid peroxidation in laminitic laminae59, there is no evidence that pro-MMP9 is oxidized or active in the laminae. Indeed, there is little evidence of laminar degradation in
horses with OG1-lameness even when the laminae of these animals contain large numbers of
immigrant neutrophils and highly elevated levels of pro-MMP-956.
An elevated level of MMP-2 in the laminae is a characteristic of horses with chronic
relapsing laminitis and with starch gruel-induced laminitis at OG3-lameness53. However, little or
no MMP-2 is present at OG1-lameness in horses with BWE-induced56 or starch gruel-induced
lameness (Wang and Black, unpublished data). Thus, MMP-2 may contribute to the
deterioration of the laminae in severe disease only, or may be induced as a component of a
repair response. Furthermore, whereas the concentration of MMP-2 is significantly elevated in
the laminae of horses with starch gruel-induced laminitis at OG3-lameness compared to that in
healthy horses, some horses develop starch gruel-induced OG3-lameness in the absence of
elevated laminar MMP-2 and an occasional control horse can express a high level of MMP-2 in
the laminae without showing signs of lameness 53. Thus, metalloproteinases other than MMP-2
and MMP-9 are likely to contribute to degradation of the laminae in laminitis.
We have recently reported that the gene encoding ADAMTS-4 is expressed in the laminae of
healthy horses and over-expressed in the laminae of horses with experimentally induced (black
walnut heartwood toxemia and starch gruel overload models) and naturally acquired laminitis 28.
Furthermore, we have shown that ADAMTS-4 protein is constitutively expressed in the laminae
of healthy horses as a 51 kDa form60. Catalytic activity was inferred both by catalytic site
neoepitope exposure, which is indicative of prior removal of the regulatory propeptide, and by
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the presence in the tissue of ADAMTS-4 cleavage fragments of aggrecan and versican60.
Aggrecan and versican are large polysulfated proteoglycans and primary substrates of ADAMTS429,61,62. Anionic groups on their glycosaminoglycan (GAG) side chains carry with them positively
charged counter ions, such as Na+, creating an osmotic gradient and drawing water into the
tissue. In combination with hyaluronan the proteoglycans form hydrated gels that endow
tissues with resistance to compression deformation30,34,61. In addition, aggrecan and versican
have signaling properties that affect cell proliferation, differentiation, adhesion and intercellular
communication49,62,63 and hence have additional, non-mechanical, roles in regulating cell
function.
In healthy horses aggrecan and hyaluronan are present throughout the digital secondary
epidermal laminae and enriched within the basal epithelial cell layer, which abuts the basement
membrane60. Versican has a more restricted distribution than aggrecan, localizing solely to the
basal epithelial cells. Based on their biochemical and biological properties and on their tissue
distribution, it is feasible that the proteoglycans affect development and maintenance of the
basal epithelial cell layer as well as cushion basal epithelial cells against the severe
biomechanical stresses associated with their anatomical location. Elevated ADAMTS-4 gene
expression in laminitic laminae28, if it is accompanied by elevated enzyme expression and
degradation of its proteoglycan substrates, may therefore play a critical role in failure of the
laminae.
Here we show that elevated expression of the gene encoding ADAMTS-4 in laminitic laminae
is accompanied both by an increase in the amount of ADAMTS-4 protein in the tissue and by
increased amounts of fragments of versican bearing ADAMTS-4 cleavage-neoepitopes.
Furthermore, in severely laminitic laminae, expression of the gene encoding versican is
drastically reduced and versican is substantially depleted from the basal epithelial cell layer. The
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studies show a dramatic change in versican expression and processing in the basal epithelium of
laminitic laminae, which may compromise basal epithelial cell function and the association of
epidermal and dermal layers of the laminae.

3.2 Results
3.2.1

Gene Expression

3.2.1.1 ADAMTS-4
Analysis by RT-qPCR using GAPDH as the reference gene showed that ADAMTS-4 gene
expression was significantly (P<0.05) elevated in the digital laminae of horses that developed
OG1-lameness (n=6) after receiving starch gruel, compared to that in laminae of healthy control
horses (n=8) (Fig 3.1). There was also a trend towards elevated ADAMTS-4 gene expression in
the digital laminae of horses at a developmental phase of laminitis corresponding to onset of
fever (n=6), and at OG3 lameness (n=5). However in these cases mean fold ADAMTS-4 induction
values were lower than those in the laminae of horses with OG1-lameness, there was
considerable sample variation, and mean values did not differ significantly from those in
laminae of healthy horses.

3.2.1.2 Versican
Analysis by RT-qPCR using GAPDH as the reference gene, and primers specific for
versican-G1, αGAG, βGAG and C terminal domains (Fig 3.2A), showed that expression of the
gene encoding versican increased slightly at OG1-lameness (n=6) but declined substantially (2.5
fold) and significantly (αGAG, P < 0.05; βGAG, P < 0.01; C terminal domain, P < 0.05) in the digital
laminae of horses that developed OG3-lameness (n=5) compared to that in laminae of healthy
horses (n=8). RT-qPCR analyses performed using primers specific for the G1 domain sequence
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of versican showed a similar although not significant reduction in its expression in laminae of
horses with OG3-lameness compared to laminae from healthy horses (Fig 3.2A).

3.2.1.3 Aggrecan
Analysis by RT-qPCR using GAPDH as the reference gene showed that while mean fold
expression of the gene encoding aggrecan was lower in laminae of horses with OG3 lameness
(n=5) compared to that in laminae of healthy control horses (n=8), the values did not differ
significantly (Fig 3.2B).

3.2.2

Protein Expression

3.2.2.1 ADAMTS-4
Analyses by SDS-PAGE and Western blotting showed that two ADAMTS-4 polypeptides
of 61 kDa and 51 kDa bearing the bearing the active site neopitope FASLSRFVET 64 were
significantly (≈2 fold, P ≤ 0.05 in each case) elevated in 0.5% NP-40 extracts of laminae of horses
with OG1-lameness (n=6) relative to that in the laminae of control horses (n=8) (Fig 3.3). The 51
kDa form of ADAMTS-4 was more prevalent than the 61 kDa form in these and all other samples
of laminae analyzed. β actin, which is expected to remain constant in the tissue throughout
development of laminitis, as is the case with β actin gene expression (data not shown), was used
as a loading control to normalize values and a sample from the same protein extract was run in
each blot (boxed in Fig 3.3) to facilitate comparisons between blots. The 61 kDa and 51 kDa
ADAMTS-4 expression values did not differ significantly between OG3 and control samples of
laminae mirroring results of ADAMTS-4 gene expression analyses (Fig 3.1).
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3.2.2.2 V0 and V1 Versican
ADAMTS-4 cleaves V0 and V1 versican isoforms within the βGAG domain yielding 66 kDa
and 109 kDa G1- βGAG fragments with a characteristic C terminal ADAMTS-4 DPEAAE cleavage
neoepitope65. Equine lamellar versican fragments bearing the DPEAAE neoepitope are fully
extracted into 0.5% NP-40 (data not shown). Comparative analysis of 0.5% NP-40 extracts of
laminae from healthy horses and from horses with starch gruel-induced laminitis showed that
the amount of the 66 kDa V0/V1 versican ADAMTS-4 cleavage fragment was significantly
elevated (≈2.5 fold, P < 0.001) in the laminae of horses with OG3-lameness (n=5) relative to that
in the laminae of control horses (n=8) (Fig 3.4). The amount of the 109 kDa V0/V1 ADAMTS-4
versican cleavage fragment was also raised (≈2 fold) in OG 3 relative to control laminae,
although this increase was not statistically significant. However, paired analyses of 109 kDa and
66 kDa ADAMTS-4 cleavage fragments of V0/V1 versican showed these to be strongly, and
highly significantly, positively correlated (Pearson’s r = 0.70, P < 0.001, r2 = 0.49) suggesting coordinate generation. Differential retention of the cleavage fragments in laminae, or selective
further degradation in the laminae may account for unexplained variance in their respective
abundance.

3.2.2.3 V0 and V2 Versican
V0 and V2 versican isoforms are constitutively cleaved by ADAMTS-4 yielding G1-αGAG
fragments bearing a C terminal ADAMTS-4 NIVSFE cleavage neoepitope45. NIVSFE positive
polypeptides of 112 kDa, 68 kDa, 56 kDa, 34 kDa and 21 kDa were detected in extracts of
laminae from healthy and laminitic horses (Fig 5). Comparative analysis of 0.5% NP-40 extracts
of laminae from healthy horses and from horses with starch gruel-induced laminitis, which
contain all extractable NIVSFE-neoepitope bearing material, showed that the presence of the
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112 kDa polypeptide was substantially and significantly reduced (≈8 fold, P < 0.001) in extracts
of laminae from horses with OG1- (n=6) and OG3-lameness (n=5) compared to that in extracts of
control laminae (n=8) (Fig5D) and this was paralleled by a decline (≈3 fold, P < 0.01) of the 56
kDa NIVSFE positive fragment (Fig 5D). The levels of the 112 kDa and 56 kDa fragments were
strongly and significantly positively correlated (Pearson’s r = 0.76, P = 0.0001, r 2 = 0.58),
consistent with co-ordinate processing.
The reduction of the 112 kDa and 56 kDa V0/V2 versican fragments bearing the
ADAMTS-4 cleavage neoepitope NIVSFE in laminitic laminae was accompanied by an increase of
the 68 kDa (≈2.5 fold, P < 0.01), 34 kDa (≈3 fold, P < 0.001) and 21 kDa (≈9 fold, P < 0.01)
polypeptides bearing the NIVSFE neoepitope. These polypeptides showed moderate to strong
positive paired correlations (n=19; 68 kDa vs 34 kDa - Pearson’s r = 0.47, P < 0.05; 68 kDa vs 21
kDa - Pearson’s r = 0.79, p < 0.0001; 34 kDa vs 21 kDa - Pearson’s r = 0.73, P = 0.0004) consistent
with a co-ordinate processing.

3.2.2.4 Correlation Analysis of the 66 kDa DPEAAE-positive and 34 kDa and 21 kDa NIVSFEpositive Versican Fragments
Results presented in Figure 3.4 show that the concentration of the 66 kDa ADAMTS-4
cleavage fragment of V0/V1 versican increases in laminitic laminae compared to that in healthy
laminae. Similarly, those in Figure 3.5 show that the levels of the 34 kDa and 21 kDa ADAMTS-4
fragments also increase in laminitic laminae compared to healthy laminae. A paired comparison
of these data shows that there is a strong positive correlation between the concentrations of
the 66 kDa V0/V1 versican fragment and the 34 kDa V0/V2 versican fragment (Pearson’s r =
0.77, P < 0.0001, r2 = 0.59), and to a lesser extent between the 66 kDa and 21 kDa putative
V0/V2 versican fragment (Pearson’s r = 0.53, P = 0.02, r2 = 0.28) consistent with co-ordinate
processing of the V0/V1 and V0/V2 versican isoforms by ADAMTS-4. Unexplained variance may
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result from differential synthesis of V0, V1 and V2 versican isoforms relative to ADAMTS-4, or
from differential fragment stability, or laminar retention in vivo.

3.2.2.5 Aggrecan
ADAMTS-4 cleavage fragments of aggrecan could be extracted from laminae in 4M
guanidine hydrochloride but not 0.5% NP-40. Extracted material was digested with
chondroitinase ABC to remove chondroitin sulfate glycosaminoglycans. Chondroitin sulfate
glycosaminoglycan-free aggrecan fragments bearing the ARGSVI44 ADAMTS-4 cleavage
neoepitope had MWs of, 250 kDa, 70 kDa and 50 kDa (Fig 3.6). Relative amounts of the 250 kDa
and 50 kDa polypeptides were similar in extracts of laminae from healthy horses (n=8) and
laminae from horses with OG1- (n=6) or OG3-lameness (n=5). The detection of the 70 kDa
polypeptide decreased (≈2.5 fold, P < 0.001) in laminae from horses with OG3-lameness relative
to that in extracts of normal laminae. For these analyses a common sample was included in
each gel (boxed in Fig 3.6A) and used to normalize data. Actin was not detected in the
preparations excluding its use as a loading control, but an equivalent amount of total protein
was loaded in each lane.

3.2.3

Protein Distribution

3.2.3.1 Aggrecan and Versican
Indirect immunofluorescence was performed on thin frozen sections of laminae from
healthy horses and horses with starch gruel-induced laminitis to determine whether elevated
ADAMTS-4 gene and protein expression affects the distribution of aggrecan or versican. In
these sections, nuclei were stained blue with DAPI, and aggrecan or versican were stained red
using specific antibodies (Fig 3.7). Images obtained from sections of laminae from a control
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horse (Figs 3.7A and E), a horse with OG1-lameness (Fig 3.7B and F) and a horse with OG3lameness (Fig 3.7C and G) are presented, and are representative of those from animals in each
group (control n=6; OG1 n=6; OG3 n=4). Within each field, basal epithelial cells were examined
for their mean intensity of red fluorescence and 60 fields were analyzed for each section, from
each sample of laminae. Results obtained from OG1 and OG3 samples were compared to those
from control laminae and are presented in Figures 3.7D and H.
Results presented in Figure 3.7 show that the distributions of aggrecan and versican are
the same in the laminae of control and laminitic horses. In all samples, aggrecan was present in
the secondary epidermal laminae only and enriched in basal epithelial cells. In all samples,
versican was solely present in basal epithelial cells of the secondary epidermal laminae. The
intensity of aggrecan staining in basal epithelial cells of the secondary epidermal laminae was
not affected by the development of laminitis as indicated by quantified specific staining (Fig
3.7A-D). In contrast, the level of versican was substantially (≈3 fold) and significantly lower in
the laminae of horses with OG3-lameness than in the laminae of healthy horses (p<0.01) and
those with OG1-lameness (p<0.05) (Fig 3.7E-H). The level of versican in laminae of horses with
OG1-lameness did not differ significantly from that in laminae of healthy control horses.

3.2.3.2 Laminin and Actin
Immunofluorescence analyses were also performed on thin frozen sections of laminae
from healthy horses and horses with starch gruel-induced laminitis to examine the relationship
of the basement membrane and basal epithelial cells. Basement membrane laminin was stained
red with a specific antibody, and cortical actin of basal epithelial cells was stained green with
FITC-phalloidin. Results from a control horse, a horse with OG1-lamness and a horse with OG3lameness are presented (Figure 3.8) and are representative of all horses in each group (control
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n=6; OG1 n=6; OG3 n=4). These results recapitulate histochemical observations reported by
other investigators66, briefly basal epithelial cells in laminae of horses with OG3-lameness
appear flattened and spread on the basement membrane compared to those of healthy horses.
In addition, in some locations the basement membrane has pulled free of the tips of secondary
epidermal laminae, and is also separated from basal epithelial cells in crypt regions of the
secondary epidermal laminae (Fig 3.8C arrows).

3.3 Discussion
We show here that starch gruel induced laminitis causes an increase in ADAMTS-4 gene
expression in the front hoof laminae of horses confirming earlier studies 28. In addition, we show
that the increase in ADAMTS-4 gene expression is accompanied by an increase in ADAMTS-4
activity, a decrease in versican gene expression that occurs between OG1- and OG3-lameness,
increased concentrations of low molecular weight (MW) ADAMTS-4 cleavage fragments of
V0/V1 and V0/V2 versican in the tissue, depletion of versican from basal epithelial cells and
regional separation of basal epithelial cells from the basement membrane. Although a direct
pathophysiological consequence of versican loss cannot be established from the present study,
this loss, together with changes in ADAMTS-4 and versican gene expression, indicates a global
change in basal epithelial cell physiology which may contribute to detachment of the epithelial
cells from the basement membrane and the development of severe lameness. This conclusion is
consistent with previous studies showing reduced desmosomal attachments of basal epithelial
cells to adjacent basement membrane in laminitic tissue2.
There was a moderate but significant positive correlation between expression of genes
encoding versican and aggrecan in laminae. However, analyses in other systems indicate that
expression of these genes does not fit a straightforward program of co-regulation. For example,
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both aggrecan and versican gene expression are elevated in porcine chondrocytes subjected to
microgravity67, whereas in ruptured Achilles tendons, aggrecan gene expression is elevated and
that of versican depressed68. Furthermore, exposure of equine articular cartilage to IL-1β elicits
elevated versican gene expression but reduced aggrecan gene expression 69.
Both ADAMTS-4 and versican gene expression declined in the laminae of horses with OG3lameness relative to that in horses with OG1-lameness although to differing degrees.
Nevertheless, there was a moderate positive correlation between expression of genes encoding
ADAMTS-4 and versican, which is consistent with studies in other systems. For example,
incubation with TGFβ1 causes up-regulation of versican gene expression in human skin70 and
bronchial epithelial cells71, as well as up-regulation of ADAMTS-4 gene expression in cultured
human tendon cells72, and of both genes in prostatic stromal cells 73. A deeper analysis of
signaling pathways that regulate expression of genes encoding ADAMTS-4, versican and
aggrecan in laminar basal epithelium awaits the development of appropriate cell lines.
The elevated presence of ADAMTS-4 in laminae of horses with starch gruel induced
laminitis was accompanied by a significantly elevated presence of V0/V1 and V0/V2 versican
fragments bearing ADAMTS-4 cleavage neoepitopes. Although aggrecan is a recognized
substrate of ADAMTS-429 and is present together with ADAMTS-4 and versican in basal epithelial
cells of the laminae60, the relative amount of aggrecan fragments bearing ADAMTS-4 cleavage
neoepitopes did not increase in laminitic laminae. The most likely interpretation of these
surprising data is that aggrecan and versican are differentially cleaved by ADAMTS-4 in laminitic
laminae. Differential cleavage of versican versus aggrecan might result from differential
specificity of the 51 kDa truncated form of ADAMTS-4, which is the predominant form in
laminae, for these substrates, or from unequal partition of ADAMTS-4 into distinct aggrecan and
versican rich compartments, or both. In this regard, C terminal autoproteolytic truncation of
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ADAMTS-4, which results in generation of the ~51 kDa form, has been shown to reduce the
specificity of ADAMTS-4 for sulfated GAGs74 and to alter its substrate range42,75,76.
Levels of 68 kDa, 34 kDa and 21 kDa V0/V2 versican cleavage fragments bearing the
ADAMTS-4 cleavage neoepitope NIVSFE were drastically increased in the laminae of horses with
OG1- and OG3-lameness compared to laminae of healthy horses. Cleavage of both V0 and V2
versican isoforms by ADAMTS-4 occurs within the αGAG domain and is expected to yield a G1αGAG fragment that corresponds to the 68 kDa fragment reported here45,60. Additional cleavage
of this fragment is required to yield the 34 kDa and 21 kDa fragments. It remains to be
determined whether C terminal truncation of equine ADAMTS-4 endows it with this additional
catalytic activity, or whether other proteases are involved. It also remains to be determined
whether the low MW V0/V1 and V0/V2 versican fragments, shown here to accumulate in
laminitic laminae and to be soluble, are secreted and have biological activity that contributes to
the pathophysiology of laminitis.
Retention of aggrecan and loss of versican from basal epithelial cells during laminitis
does not fit with the simple idea that cleavage of polysulfated proteoglycans by ADAMTS-4
removes a protective gel layer thus increasing the vulnerability of basal epithelial cells to
compression and concussion forces. Of the two large polysulfated proteoglycans, aggrecan is
the most heavily substituted with chondroitin sulfate29,30,31 and consequently would be expected
to have the greater impact on retaining water in the tissue. In addition to its role as a biological
cushion, versican has also been shown to regulate a wide range of cell functions including
proliferation, migration, and death. Of particular interest is the ability of recombinant V1
versican to induce mesenchymal to epithelial cell transition of the NIH3T3 fibroblast cell line and
to regulate expression of cadherins and connexins increasing cell adhesion and communication
through gap junctions63,77. Also of interest is the ability of recombinant V2 versican to inhibit cell
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proliferation. If V1 and V2 versican isoforms exert these regulatory functions in basal epithelial
cells of the equine digital laminae, their depletion through reduced gene expression and
ADAMTS-4 cleavage, might lead to functional modification of the basal epithelial cells.
Furthermore, differential depletion of V1 and V2 versican isoforms, which can be inferred from
the greater accumulation in laminae of V0/V2 compared to V0/V1 versican ADAMTS-4 cleavage
fragments, would be expected63,77,78 to favor an elevation in proliferation of the basal epithelial
cells combined with some loss of phenotype.
Based on the above, we propose that versican plays a key role in regulating basal
epithelial cell physiological properties in the equine digital laminae. Further, we propose that its
depletion through cleavage by ADAMTS-4 and down regulation of gene expression in laminitic
laminae is responsible for the observed changes in the basal epithelial cells and their
detachment from the basement membrane, thus, contributing to separation of the laminae at
the epidermal-dermal junction.
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3.4 Chapter 3 Figures

Figure 3.1
ADAMTS-4 Gene Expression in Healthy and Laminitic Laminae: RNA was extracted from three
separate sections of dorsal lamina from each horse and reverse transcribed into cDNA.
Quantitative real-time PCR was performed in triplicate for each cDNA preparation using
optimized gene-specific primers to analyze gene expression levels of ADAMTS-4 normalized to
GAPDH in corresponding samples. The study was repeated using different sections of dorsal
laminae. For each gene, primers were selected so that they do not amplify genomic DNA. * P <
0.05 compared with the control animals, determined from 95% confidence intervals of the
treated samples by 1-way ANOVA. Results are mean ± 1SD. CON (n=8), DEV (n=6), OG1 (n=6),
OG3 (n=5).
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Figure 3.2
Aggrecan and Versican Gene Expression in Healthy and Laminitic Laminae: RNA was extracted
from three separate sections of dorsal lamina from each horse and reverse transcribed into
cDNA. Quantitative real-time PCR was performed in triplicate for each cDNA preparation using
optimized gene-specific primers to analyze gene expression levels of versican (A) and aggrecan
(B) normalized to GAPDH in corresponding samples. The study was repeated using different
sections of dorsal laminae. * P < 0.05, **<0.01 compared with the control animals, determined
from 95% confidence intervals of the treated samples. Results are mean ± 1SD. CON (n=8), OG1
(n=6), OG3 (n=5).

43

Figure 3.3
ADAMTS-4 Protein Expression in Healthy and Laminitic Laminae: Western blots of 0.5% NP-40
extracts (30 μg protein/lane) from laminae of: A) healthy horses (CON; n=8), B) horses with
OG1-lameness (n=6) and C) horses with OG3- lameness (n=5). Samples were subjected to SDSPAGE in 10% gels, polypeptides transferred to polyvinylidine fluoride membrane and blots
probed using an antibody against neoepitope FASLSRFVET exposed on ADAMTS-4 catalytic
domain after removal of the regulatory propeptide. Blots were stripped and probed with an
antibody specific for β-actin, which was used as a loading control. The bands enclosed by the
black box are from a common sample (from the OG1 group) that was run in all gels and used for
normalizing experiment variation. D) The intensity of chemiluminescence was quantified and
values were statistically analyzed. * P < 0.05 compared with the control, determined from 95%
confidence intervals of the treated samples.
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Figure 3.4
V0/V1 Versican Protein Expression in Healthy and Laminitic Laminae: Western blots of 0.5%
NP-40 extracts (30 μg protein/lane) from laminae of : A) healthy horses (CON; n=8), B) horses
with OG1-lameness (n=6) and C) horses with OG3-lameness (n=5). Samples were subjected to
SDS-PAGE in 10% gels, polypeptides transferred to polyvinylidine fluoride membrane and the
blots probed using antibodies to the neoepitope DPEAAE of versican V0/V1 generated by
ADAMTS 4. β-actin was used as load control. The bands enclosed by the black box represent a
common sample (from the OG1 group) that was run in all gels and used for normalizing
experiment variation. D) The intensity of chemiluminescence was quantified and values were
statistically analyzed. *** P<0.001 compared with the control.
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Figure 3.5
V0/V2 Versican Protein Expression in Healthy and Laminitic Laminae: Western blots of 0.5%
NP-40 protein extracts (30 μg protein/lane) from laminae of: A) healthy horses (CON; n=8), B)
horses with OG1-lameness (n=6) and C) horses with OG3-lameness (n=5). Samples were
subjected to SDS-PAGE in 10% gels, polypeptides transferred to polyvinylidine fluoride
membrane and blots probed using antibodies to the neoepitope NIVSFE of versican V0/V2
generated by ADAMTS 4. β-actin was used as load control. The bands enclosed by the black box
represent a common sample (from the OG1 group) that was run in all gels and used for
normalizing experiment variation. D) The intensity of chemiluminescence was quantified and
values were statistically analyzed. ** P< 0.01, *** P<0.001 compared with the control,
determined from 95% confidence intervals of the treated samples.
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Figure 3.6
Aggrecan Protein Expression in Healthy and Laminitic Laminae: Western blots of
hyaluronidase- and chondroitinase ABC- digested 4M guanidine hydrochloride extracts (30 μg
protein/lane) from laminae of: A) healthy horses (CON; n=8), B) horses with OG1-lameness (n=6)
and C) horses with OG3-lameness (n=5). Samples were subjected to SDS-PAGE in 10% gels,
polypeptides transferred to polyvinylidine fluoride membrane and blots probed using antibodies
to the aggrecan neoepitope ARGSVIL generated by ADAMTS 4. The bands enclosed by the black
box represent a common sample (from the OG1 group) that was run in all gels and used for
normalizing experiment variation. D) The intensity of chemiluminescence was quantified and
values were statistically analyzed. *** P<0.001 compared with the control, determined from
95% confidence intervals of the treated samples.
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Figure 3.7
Distribution of Aggrecan and Versican in Healthy and Laminitic Laminae: Thin sections of
frozen laminae from: (A,E) a representative healthy horse, (B,F) a representative horse with
OG1-lameness, and (C,G) a representative horse with OG3-lameness were stained red with
antibodies against (A-C) aggrecan and (E-G) versican. Autofluorescent laminae components
(putatively collagen and keratin) fluoresce in green, nuclei are stained blue with DAPI. Scale
bars 50μm. Average fluorescence was quantified and statistically analyzed using 2-way ANOVA
and Duncan’s post test. D) Quantification of aggrecan expression in sections from laminae of
healthy horses (n=6) and horses with OG1 (n=6) and OG3 (n=4) lameness, H) quantification of
versican in sections from laminae of healthy horses (n=8) and horses with OG1 (n=6) and OG3
(n=4) lameness. ** p<0.01, *p<0.05.
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Figure 3.8
Histological Structure of Healthy and Laminitic Laminae: Thin sections of laminae from: (A) a representative healthy horse, (B) a
representative horse with OG1-lameness and (C) a representative horse with OG3-lameness were stained with an antibody against laminin
(red) to visualize the basement membrane, and phalloidin-FITC to visualized intracellular cortical actin (green). Nuclei stained in blue with
DAPI. Scale bars 50μm.
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CHAPTER 4
IMPACT OF LAMINITIS ON THE CANONICAL WNT SIGNALING PATHWAY IN BASAL EPITHELIAL
CELLS OF THE EQUINE DIGITAL LAMINAE

4.1 Introduction
Failure of the laminar epidermal:dermal junction in horses with starch-gruel induced
laminitis, which is a model for natural disease 6, is associated with physiological changes in
laminar basal epithelial cells (LBEC). These include a diminished number of hemidesmosomes
per unit area of basement membrane2,51, expression of the stress protein calprotectin54,
elevated gene and protein expression of A Disintegrin And Metalloproteinase with
Thrombospondin Motifs-4 (ADAMTS-4)28 and depletion of intracellular versican by a
combination of elevated ADAMTS-4 cleavage and suppressed versican gene expression79.
Versican gene expression is linked to mesenchymal to epithelial transition in cell culture
experiments and the proteoglycan induces mesenchymal to epithelial transition of metastatic
tumor cells accelerating their proliferation 80. Consequently, the depletion of versican from LBEC
in laminitic horses may affect epithelial cell lineage commitment and associated functions that
are critical to maintaining the laminar epidermal:dermal junction. Furthermore, rat and human
versican gene expression can be induced by the β-catenin/TCF transcription complex81,82 and
thus, is regulated by the canonical Wnt signaling pathway (reviewed in 83-85), raising the possibility
that suppressed versican gene expression in LBEC of horses presenting laminitis may result from
perturbations in the canonical Wnt signaling pathway.
The canonical Wnt signaling pathway is one of the fundamental pathways that control cell
development, proliferation, differentiation, polarity and motility. The core activity of the
pathway is regulation of the production and stability of β-catenin in the cell. This is important
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because β-catenin mediates canonical Wnt signaling by binding to and activating members of
the T cell factor (TCF) transcriptional factor family. The canonical Wnt signaling pathway
regulates expression of genes encoding versican36,81 and many other proteins. Pathway
components that elevate production and stability of β-catenin are called “positive regulators”.
These are: (i) Wnt, named after Wingless in Drosophila and integration 1 in mouse breast
tumors, which is a glycoprotein that activates the pathway, (ii) its receptor, frizzled (FZD), (iii) its
co-receptor, low density lipoprotein receptor related protein (LRP); (iv) disheveled (Dsh) which
together with the Wnt/FZD/LRP complex forms a signalosome that inhibits glycogen synthase
kinase 3β (GSK3β) thus stabilizing β-catenin by preventing its phosphorylation and therefore its
ubiquitination and proteasomal degradation, (v) protein phosphatase 1 (PP1) and protein kinase
B (Akt), which also prevent β-catenin phosphorylation, and (vi) TCF which in complex with
transcriptional co-activator β-catenin induces target gene expression. Pathway components that
diminish expression of β-catenin and elevate its degradation are called “negative regulators”.
These are: (i) Dickkopf (DKK), which antagonizes Wnt signaling by binding the co-receptor LRP,
(ii) components of the β-catenin degradation complex, namely, the scaffolding proteins Axin and
adenomatous polyposis coli gene product (APC) which bind β-catenin, and (iii) casein kinase 1α
(CK1α) and GSK3β which jointly phosphorylate bound β-catenin leading to its subsequent
ubiquitination and proteasomal degradation.
Here we determine: i) whether suppressed versican gene and protein expression which
occurs in LBEC of laminitic horses83 is accompanied by changes in expression of E-cadherin and
vimentin, and hence with a change in the lineage commitment of the cells, ii) whether positive
and negative regulatory components of the canonical Wnt signaling pathway are expressed in
LBEC and if so, how expression levels change during the development of laminitis, and iii)
whether the development of laminitis is accompanied by changes in expression of components
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of adherens junctions (E-cadherin and β-catenin) and hemidesmosomes (integrin α6 and
integrin β4).

4.2 Results
4.2.1

Integrin β4, β-Catenin, and Vimentin Gene and Protein Expression
In the laminae of both healthy horses and of horses with starch gruel-induced laminitis,

expression of the hemidesmosome component integrin β4 is restricted to the single layer of
basal epithelial cells of the secondary epidermal laminae (Fig 4.1A, B and C; stained red with
specific antibody). The protein is detected throughout the basal epithelial cell cytoplasm, and a
portion is present at the cell margin adjacent to the basement membrane (Fig 4.1D, E and F;
stained green with anti-pan-laminin), as indicated by co-localization (Fig 4.1G, H and I; stained
yellow as a result of merged green and red stains at the integrin β4:laminin interface). The level
of expression of the gene encoding integrin β4 is significantly reduced in laminae of horses
presenting OG3 lameness compared to that in healthy horses (Fig 4.1J). In addition, there is a
significant drop in integrin β4 protein concentration in extracts of laminae from horses
presenting OG1 and OG3 lameness compared to those prepared from healthy horses (Fig 4.1K;
Western blots shown in Fig 4.2, panel A). In horses with starch-gruel induced laminitis,
suppressed integrin β4 gene and protein expression (Fig 4.1J and K) is accompanied by
separation of the basement membrane and basal epithelial cells in focal areas proximal to the
primary epidermal laminae (Fig 4.1I; indicated by white ovals) a condition that is not observed in
sections of laminae from healthy horses or horses presenting OG1 lameness.
Reduced expression of integrin β4 in laminitic laminae is accompanied by reduced gene
and protein expression of the adherens junction and canonical Wnt signaling pathway
component β-catenin (Fig 4.3A and 3B; Western blots shown in Fig 4.2, panel B). In addition, the
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level of expression of the gene encoding β-catenin in laminae correlates strongly and positively
with that of the gene encoding integrin β4 (Fig 4.3C Pearson’s r = 0.74; p=0.0003) consistent
with the possibility that expression of these genes is co-regulated. Like integrin β4, β-catenin is
highly expressed in LBEC of healthy and laminitic horses (Fig 4.3 D-G; stained red with specific
antibody), where it is richly present around cell margins (Fig 4.3E). E-cadherin is also highly
expressed in these cells (Fig 4.3H-J; stained green with specific antibody) and for the most part
co-localizes with β-catenin (Fig 4.3K-M; stained yellow as a result of merged green and red
stains) to which it is tethered in adherens junctions.
Gene (at OG1) and protein (at OG3) expression of the type III intermediate filament
protein vimentin, which is a marker of mesenchymal cells86, is significantly elevated in the
laminae of laminitic horses compared to laminae of healthy horses (Figs 4.4G and H; Western
blots shown in Fig 4.2, panel C). Vimentin protein (stained red with specific antibody) is
expressed by cells of the primary and secondary dermal laminae of healthy and laminitic horses
but not by cells of the epidermal laminae (Figs 4.4A – F). LBEC from healthy horses (Fig 4.4A and
D) and from horses presenting OG1 (Fig 4.4B and E) or OG3 (Fig 4.4C and F) lameness have a
well-developed cortical actin cytoskeleton which stains green with phalloidin-FITC and do not
express vimentin. Hence, elevated vimentin gene and protein expression in laminae of laminitic
horses (Figs 4.4G and H) is restricted to cells of the dermal connective tissue.

4.2.2

Expression of Canonical Wnt Signaling Pathway Components
Levels of β-catenin protein expression are regulated by the canonical Wnt signaling

pathway. Levels of β-catenin gene expression may also be regulated, directly and indirectly, by
the canonical Wnt signaling pathway 87. Consistent with suppressed β-catenin gene and protein
expression in laminitic laminae, expression of genes encoding positive canonical Wnt signaling
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pathway regulators, namely Wnt4, FZD4, LRP6, Dsh and PP1, is also suppressed (Fig 4.5A-E).
Furthermore, immunofluorescence staining shows that Wnt4 is mainly expressed in the basal
and supra-basal epithelial cells of the secondary epidermal lamellae of healthy and laminitic
horses (Fig 4.6A, B, C; stained red with specific antibody), while FZD4 is mainly expressed in LBEC
(Fig 4.6D, E, F; stained red with specific antibody).
Whereas expression of genes encoding positive regulators of the canonical Wnt
signaling pathway is suppressed in the laminae of laminitic horses (Fig 4.7A-E), expression of
genes encoding components of the β-catenin degradation complex (negative regulators of the
canonical Wnt signaling pathway) is either transitorily elevated, namely, Axin 1 and CK1α (Fig
4.5F and H), suppressed, namely, APC (Fig 4.5G), or unaltered, namely, GSK3β (Fig 4.5I).
Although the level of GSK3β gene expression is unaltered in the laminae of laminitic horses
relative to that in the laminae of healthy horses, the level of GSK3β protein increases in laminitic
laminae (Fig 4.7A), that of serine-9-phospho-GSK3β (p-GSK3β) is unchanged (Fig 4.7B), and ratio
of p-GSK3β to total GSK3β decreases (Fig 4.7C; Western blots shown in Fig 4.2, panel D and E).
Expression of the gene encoding Akt2, which is known to phosphorylate GSK3β and accelerate
its degradation88, was also reduced in laminae of laminitic compared to healthy horses (Fig
4.7D).
Finally, expression of the gene encoding TCF4, which in complex with transcriptional coactivator β-catenin induces target gene expression in the canonical Wnt signaling pathway77, is
suppressed in laminitic laminae (Fig 4.8A). Furthermore, comparative analyses of gene
expression in laminae of all control, OG1 and OG3 animals show there are strong positive
correlations between the expression of genes encoding β-catenin and TCF4 and those encoding
some positive and negative regulators of the canonical Wnt signaling pathway (Fig 4.8B)
consistent with feed forward regulatory loops. Most notable among these are TCF4 and the
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positive pathway regulator LRP-6 (Pearson’s r = 0.8580, P<0.0001), and TCF4 and the negative
regulators GSK3β (Pearson’s r = 0.7800, P<0.0001) and APC (Pearson’s r = 0.8174, P<0.0001).
A strong positive correlation was also observed between the gene encoding TCF4 and that
encoding versican (Pearson’s r = 0.89, P < 0.0001), and a moderate positive correlation between
the gene encoding β-catenin and that encoding versican (Pearson’s r = 0.64, P = 0.003). In
addition, there was a strong positive correlation between expression of the gene encoding TCF4
and that encoding integrin β4 (Pearson’s r = 0.69, P = 0.001), and between the gene encoding
and β-catenin and integrin β4 (Pearson’s r = 0.74, P = 0.0003).

4.3 Discussion
Studies reported above show that genes and proteins encoding multiple positive regulators
of the Canonical Wnt Signaling Pathway were decreased in the laminae of horses affected by
laminitis. In addition, many of the known negative regulators of the wnt pathway were
increased in the same conditions suggesting that the wnt signaling pathway is negatively
regulated during the progression of laminitis. This possibility is further supported by evidence
that Versican, one of the known targets of the Wnt pathway81,82, is significantly decreased
during laminitis progression79. In addition, expression of versican in laminae correlated
positively with expression of genes encoding β-catenin (Pearson’s r = 0.64) and TCF4 (Pearson’s r
= 0.89, p < 0.0001) which jointly constitute the co-transcriptional activator that regulates gene
expression in the canonical Wnt signaling pathway. Determination of the importance of wnt
signaling in the progression of laminitis will require additional studies that could involve the use
of activators of the pathway, for example GSK3 inhibitors, to see if those can delay or prevent
the progression of the disease as discussed below.
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Versican gene and protein expression is associated with mesenchymal-to-epithelial cell
transition in transfected NIH 3T3 cells 63,77, and versican in extracellular matrix has been
demonstrated to promote mesenchymal-to-epithelial transition of metastatic tumor cells 89. In
addition, during development of the vertebrate heart tube, ADAMTS-mediated cleavage of
versican is associated with the formation of endocardial cushion mesenchyme 90. However, in
spite of versican depletion from LBEC of laminitic horses79, the cells did not lose their epithelial
phenotype or acquire characteristics of mesenchymal cells evidenced by the sustained
expression of the epithelial cell marker E-cadherin and lack of expression of the mesenchymal
cell marker vimentin. This is perhaps not surprising because epithelial-to-mesenchymal
transition is dependent on the canonical Wnt signaling pathway 91, which the data presented
here suggest is suppressed in LBEC of laminitic horses.
Although vimentin gene and protein were not expressed in LBEC of healthy or laminitic
horses, vimentin was strongly expressed by connective tissue cells in the dermal laminae and
expression was elevated in laminitic horses. Vimentin is a type III intermediate filament protein
present in mesenchymal cells. In addition to expression by cells undergoing epithelial to
mesenchymal transition, it is constitutively expressed by resting fibroblasts and expression is
elevated in stimulated92 and stressed cells93. Its elevated expression in laminar dermal cells of
laminitic horses is consistent with the previously shown inflammatory response occurring in this
tissue at the onset of lameness54,87, which may elicit a stress/repair response in dermal
fibroblasts.
Despite the absence of epithelial-to-mesenchymal transition in LBEC of laminitic horses,
there was evidence of impaired function. The diminished presence of positive regulators and
elevated presence of negative regulators of the canonical Wnt signaling pathway in LBEC of
laminitic horses correlated with diminished expression of β-catenin and integrin β4, which are
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components of adherens junctions and hemidesmosomes respectively 94,96 and are thus required
for basal epithelial cell:cell and cell:basement membrane attachment. Based on these
observations, we propose that suppression of the canonical Wnt signaling pathway in LBEC and
accompanying reduced integrin β4 gene and protein expression, is a contributing factor to the
reduction in number of hemidesmosomes per unit area of LBEC/basement membrane interface
reported in laminitis2.
Although the expression of genes encoding β catenin and integrin β4 was strongly positively
correlated in equine laminae (Pearson’s r = 0.74, p = 0.0003), direct regulation of integrin β4
gene expression by the canonical Wnt signaling pathway was not demonstrated, and there is no
report of this in the literature. In contrast, cross talk has been reported between the canonical
Wnt signaling pathway and other signaling pathways 96,97 and multiple lines of evidence exist that
the Wnt pathway is regulated by integrins. For example, beta1 integrin can activate Wnt via the
integrin linked kinase (ILK)98 and the adaptor protein growth factor receptor-bound-2 (Grb-2)
has been shown to be recruited by integrin β4 as a result of its interaction with collagen in the
extracellular matrix99 and to enhance β catenin-dependent Wnt signaling100. Additional studies
are required to establish whether diminished integrin β4-dependent signaling causes down
regulation of the canonical Wnt signaling pathway in laminae of laminitic horses, or vice versa,
or whether both pathways are down regulated by laminitis-associated changes in other signal
pathways.
Suppressed canonical Wnt signaling may not solely be a feature of starch gruel-induced
laminitis. In support of this possibility, it has been shown that the number of hemidesmosomes
per micrometer of basement membrane is decreased in ponies with insulin-induced laminitis101,
as it is in horses with oligofructose-induced laminitis2. In addition, preliminary proteomic
studies show that the level of β-catenin is lower in extracts of laminae from horses with
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hyperinsulinemia-induced laminitis compared to extracts of laminae from healthy horses (Dr.
Hannah Galantino-Homer, Personal Communication). It is important to point out that the
diminished presence of β-catenin in extracts of laminae from hyperinsulinemic animals does not
necessarily mean that the canonical Wnt signaling pathway is suppressed in the laminae of
these animals; given that β-catenin is sequestered by E-cadherin102, a reduction in β-catenin
expression could be compensated by a matched reduction in E-cadherin expression. Thus, a
detailed analysis of canonical Wnt signaling pathway components and regulators is warranted in
laminae of horses presenting laminitis of diverse etiology. It is worthy of note that cross talk
between insulin/insulin like growth factor receptor signaling and the Wnt signaling pathway has
been established103 although non-canonical Wnt signaling rather than the canonical pathway is
linked to insulin resistance104,105.
If suppression of the canonical Wnt signaling pathway in LBEC is a feature of laminitis of
diverse etiology, pathway agonists may help to ameliorate laminar pathology. In this regard,
expression of genes encoding the adherens junction component E-cadherin and the
hemidesmosome component integrin α6 was not suppressed in horses with starch gruelinduced laminitis (Fig 4.9) and E-cadherin protein expression was not suppressed (Fig 4.2, panel
F) supporting the possibility that adherens junctions and hemidesmosomes might be restored by
sustaining β-catenin expression, e.g., through administration of agents that inhibit GSK3β106.
This attractive possibility is contradicted by studies showing that protein expression of integrin
α6 and anchoring filaments BP180 and laminin 5 is reduced in horses with oligofructose-induced
laminitis based on immunofluorescence staining 107, consistent with complex disruption of the
hemidesmosome. However, it is possible that the reduced expression of integrin β4 affects
expression of other hemidesmosome components. Indeed, murine keratinocytes that lack
integrin β4 also lack other hemidesmosome components 108. Clearly if suppression of the
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canonical Wnt signaling pathway proves to be a feature of laminitis irrespective of etiology, it
will be important to determine which, and to what extent, hemidesmosome, adherens junction
and desmosome components are affected in LBEC of the laminitic animals and to determine the
impact of sustaining β-catenin expression on the attachment of the basal epithelial cells to each
other and to the basement membrane. Similarly, it will be important to identify the
physiological process that results in diminished expression of β-catenin in laminae of laminitic
horses.
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4.4 Chapter 4 Figures

Figure 4.1
Distribution and Expression of Integrin β4 in Healthy and Laminitic Laminae: A-I - 10μm
sections of frozen laminae from: A, D, G - a representative (n=3) healthy horse (CON) (D – LBEC
= laminar basal epithelial cell, BM = basement membrane, SEL = secondary epidermal laminae,
PEL = primary epidermal laminae, SDL = secondary dermal laminae); B, E, H - a representative
(n=4) horse with OG1-lameness (OG1); and C, F, I - a representative (n=3) horse with OG3lameness (OG3) were stained with antibodies against integrin β4 (A,B,C - red) and against
laminin (D,E,F green). Red and Green fluorescence merge in yellow (G, H, I). Nuclei are stained
blue with DAPI. White circles indicate areas of dissociation between basal epithelial cells and
basement membrane laminin. Scale bars 50µm. J - Quantitation of integrin β4 and gene
expression relative to the gene expression of GapDH. K - Quantitation of integrin β4 protein
expression relative to β actin. Horizontal lines indicate mean ± standard error of mean of n=8
CON, n=6 OG1 and n=5 OG3, ** = p<0.01, *** = p<0.001 as calculated by one-way ANOVA.
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Figure 4.2
Wnt Signaling Pathway Protein Expression in Healthy and Laminitic Laminae: Western blots of
0.5% NP-40 extracts (30 μg protein/lane) from laminae of healthy horses (CON; n=8), horses
with OG1-lameness (n=6) and horses with OG3-lameness (n=5) showing expression of: A.
integrin β4; B. β-catenin; C. vimentin; D. GSK 3β; E. serine-9-phospho GSK3β (pGSK 3β); F. Ecadherin; β actin was used as load control. The bands enclosed by the black box represent a
common sample (from the OG1 group) that was run in all gels and used for normalizing
experiment variation. The intensity of chemiluminescence was quantified and values were
statistically analyzed shown in Fig 1K, Fig2B, Fig3H, Fig5A, B and FigS4A respectively.
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Figure 4.3
Distribution of β-catenin and E-cadherin in Healthy and Laminitic Laminae: A - Quantitation of
β-catenin gene expression relative to the gene expression of GapDH. B - Quantitation of βcatenin protein expression relative to the protein expression of β actin. Horizontal lines indicate
mean ± standard error of mean * = p<0.05 as calculated by one-way ANOVA. C - Correlation
between expression of genes encoding β-catenin and integrin β4: Pearson r= 0.7418, p=0.0003.
Solid line represents the predicted positive correlation by linear regression; Area within the
dotted lines represents 95% confidence. n=8 CON, n=6 OG1, and n=5 OG3. D-M (20X objective) 10μm sections of frozen laminae from: D, H, K - a representative (n=3) healthy horse (CON) (D –
LBEC = laminar basal epithelial cell, SBEC= supra-basal epithelial cell) ; F, I, L - a representative
(n=4) horse with OG1-lameness (OG1) and G, J, M - a representative (n=3) horse with OG3lameness (OG3) were stained with antibodies against β-catenin (D, F, G- red) and E-cadherin (H,
I, J - green). Red and Green fluorescence merge in yellow (K, L, M). Nuclei are stained blue with
DAPI. Scale bars 50µm. E (63X objective) – β-catenin stained in red, nuclei stained blue.
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Figure 4.4
Distribution and Expression of Vimentin in Healthy and Laminitic Laminae: A, B, C (20X
objective), D, E, F (63X objective) - 10μm sections of frozen laminae from a representative (n=3)
healthy horse (A,D), a representative (n=4) horse with OG1-lameness (B,E) and a representative
(n=3) horse with OG3-lameness (C,F) were stained with antibodies against vimentin (red) and
with phalloidin-FITC (green). Nuclei are stained blue with DAPI. Scale bars 50µm. G Quantitation of vimentin gene expression relative to the gene expression of GapDH. H Quantitation of vimentin protein expression relative to the protein expression of β actin.
Horizontal lines indicate mean ± standard error of mean * = p<0.05 as calculated by one-way
ANOVA. n=8 CON, n=6 OG1, and n=5 OG3.
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Figure 4.5
Gene expression of Wnt signaling pathway regulators: Expression of genes encoding A - Wnt4,
B - FZD4, C - LRP6, D - Dsh, E - PP1, F - Axin1, G - APC, H - CKIα, I - GSK3β relative to the gene
expression of GapDH. Horizontal lines indicate mean ± standard error of mean of n=8 CON, n=6
OG1, and n=5 OG3, animals. * = p<0.05, ** = p<0.01, as calculated by one-way ANOVA.
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Figure 4.6
Distribution of Wnt4 and FZD4 in Healthy and Laminitic Laminae: 10μm sections of frozen
laminae from: A, D - a representative (n=3) healthy horse (CON), B, E - a representative (n=4)
horse with OG1-lameness (OG1) and C, F - a representative (n=3) horse with OG3-lameness
(OG3) were stained red with antibodies against Wnt4 (A, B, C) and FZD4 (D, E, F) (panel F–PEL =
primary epidermal laminae). Nuclei are stained blue with DAPI. Images were taken with a 20x
objective. Scale bars 50µm.
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Figure 4.7
Protein Expression and Phosphorylation of GSK3β: A Total GSK3βprotein expression relative to
β actin; B – Phosphorylated S9 GSK3βprotein (p-GSK3β) expression relative to β actin; C -Ratio of
p-GSK3β to total GSK3β; D - Akt2 gene expression relative to GapDH. Horizontal lines indicate
mean ± standard error of mean of n=8 CON, n=6 OG1, and n=5 OG3 animals. * = p<0.05, ** =
p<0.01as calculated by one-way ANOVA.
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Figure 4.8
TCF4 Gene Expression and Correlation Summary: A - Gene expression of TCF4 relative to the
gene expression of GapDH. Horizontal lines indicate mean ± standard error of mean of n=8 CON,
n=6 OG1, and n=5 OG3 animals. B - Summary of correlation between expression of indicated
genes. * = p<0.05, ** = p<0.01, *** = p<0.001 as calculated by one-way ANOVA.
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Figure 4.9
E-cadherin Protein Expression and Integrin α6 Gene Expression: A - Protein expression of Ecadherin relative to the protein expression of β actin. B - Gene expression of integrin α6 relative
to the gene expression of GapDH. Horizontal lines indicate mean ± standard error of mean of
n=8 CON, n=6 OG1, and n=5 OG3 animals. * = p<0.05 as calculated by one-way ANOVA.
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CHAPTER 5

EXPRESSION AND ACTIVITY OF COLLAGENASES IN THE DIGITAL LAMINAE OF HORSES WITH
CARBOHYDRATE-INDUCED ACUTE LAMINITIS

5.1 Introduction
Loss of laminar structure during laminitis involves physiologic reprogramming of the
basal epithelial cells by elevated expression of ADAMTS-479, depletion of versican79, suppressed
expression of canonical Wnt signaling components 109 and depletion of hemidesmosomes
resulting in impaired basement membrane attachment2. The latter is thought to involve
degradation of ECM components by MMPs55,107,110. MMPs have been a focus of interest in
laminar pathophysiology for over a decade following: i) detection of gelatinases (MMP-2 and
MMP-9) in the digital laminae of healthy horses111, ii) elevated levels of MMP-2 and MMP-9 in
explant medium from cultured laminae of laminitic compared to healthy horses 112, iii) elevated
levels of pro-MMP-9 in the serum of horses with carbohydrate -induced laminitis compared to
healthy horses111, iv) histological evidence of extracellular matrix degradation in the laminae of
horses with carbohydrate-induced laminitis110, and v) elevated levels of collagen IV fragments in
the serum of horses with natural acquired laminitis compared to healthy horses 113. More recent
studies show that pro-MMP-9, but not regulatory propeptide-free MMP-9, is significantly
elevated in the laminae of horses with black walnut extract induced laminitis56 as a result of
neutrophil influx to the tissue. Pro-MMP-9 is also significantly elevated in the laminae of horses
with carbohydrate overload-induced and naturally acquired laminitis, where it correlates with
expression of myeloperoxidase and hence with inflammatory leukocytes. However, as in horses
with BWE-induced laminitis, the pro-MMP-9 is not processed to active enzyme in either
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condition53. Because of the retained regulatory pro-peptide, which masks the catalytic site, proMMP-9 is not catalytically active and hence is unlikely to contribute to degradation of the
laminar ECM. Indeed, since the regulatory propeptide of pro-MMP-9 is removed by proteases in
the ECM and is not removed intracellularly114, the MMP may not be secreted by inflammatory
leukocytes despite their presence in the laminae of horses presenting laminitis.
In contrast to MMP-9, both pro-MMP-2 and MMP-2 are significantly elevated in the
digital laminae of horses presenting OG3 lameness after induction with carbohydrate overload
compared to laminae of healthy horses. However, individual variation in laminar MMP-2 levels
raise concerns regarding a correlation between MMP-2 protein expression and lameness. Thus,
some severely lame horses have high levels of MMP-2 in extracts of their digital laminae, while
others have little or no MMP-253. Furthermore, few horses that express OG1 lameness after
carbohydrate-induction have MMP-2 in laminar extracts and these only at very low
concentrations (Black laboratory, unpublished). Importantly, sections of laminae from severely
lame horses do not differ from those of healthy horses with respect to levels of in situ gelatinase
activity111 indicating a lack of accumulation in the laminitic tissue of MMP-2 that is free of bound
tissue inhibitors of metalloproteinase (TIMP). These studies do not exclude a role for MMP-2 in
laminar remodeling but open the possibility that MMPs in addition to the gelatinases may
contribute to loss of lamellar function.
Here we screen several candidate MMPs in extracts of laminae from healthy horses and
horses with carbohydrate overload-induced laminitis to identify those that may contribute to
laminar pathology. We report on two, MMP-1 and MMP-13, that are significantly elevated in the
laminae of horses presenting acute laminitis compared to those of healthy horses, and map
laminitis-associated changes in the distribution of some of their known substrates.
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5.2 Results
The expression of genes encoding MMP-1, -3, -13, -14, -15 and -16 was analyzed by qRT-PCR
using primers described in Table 1; gene expression was detected in all cases in the laminae of
healthy (Figure 5.1) and laminitic horses (not shown). However, expression of genes encoding
only two of the MMPs was found to be significantly upregulated in laminae of laminitic horses
relative to their expression in laminae of healthy horses, namely MMP-1 (Figure 5.2A) and MMP13 (Figure 5.2B).
To confirm that elevations in MMP-1 and MMP-13 gene expression correspond to elevations
in protein expression, extracts of lamellar tissue were subjected to SDS-PAGE and Western
blotting. MMP-1 in extracts of laminae from healthy and laminitic horses resolved as a single
polypeptide of 52 kDa corresponding to non-glycosylated pro-MMP-1115,116 and its expression
was elevated in the laminae of horses presenting OG3 lameness but not OG1 lameness
compared to that in laminae of healthy horses (Figure 5.3A). Pro-peptide free MMP-1 was not
detected in any laminar extract. MMP-13 resolved as polypeptides of 61 kDa and 48 kDa
corresponding respectively to pro-MMP-13 (61 kDa) and MMP-13 (pro-peptide free as active
form)114,115 in extracts of laminae from healthy and laminitic horses (Fig 5.3B). Both pro-MMP-13
and active MMP-13 were elevated in the laminae of horses expressing OG3, but not OG1
lameness relative to laminae of healthy horses (Fig 5.3B). MMP-13 was further localized in
frozen laminar sections to the basal epithelium of the secondary epidermal lamellae, and
localization was not changed over the course of disease development (Fig 5.4 A-C). The
metalloproteinase has wide substrate specificity, degrading types I, III and IV collagen,
fibronectin and several other ECM components117. Type I collagen was distributed throughout
the secondary dermal laminae (SDL) of healthy horses (Fig 5.4D control) and horses presenting
OG1 lameness (Fig 5.4E, OG1), but dispersed to the edges of the SDL in horses presenting OG3

71

lameness (Fig 5.4F, OG3) leaving the appearance of multifocal gaps in the ECM. Fibronectin was
also widely distributed throughout the SDL in laminae of healthy horses (Fig 3G) and horses
presenting OG1 lameness (Fig 5.4H), but dispersed to the edges in some regions of SDL in horses
presenting OG3 lameness, (Fig 5.4I) leaving the appearance of multifocal gaps in the ECM. The
specificity of antibodies used for these stains was confirmed by dot blotting (Figure 5.5).
To further characterize the multifocal gaps that appear in the dermal ECM of horses
presenting OG3 lameness, laminae from healthy and laminitic horses were stained with
antibodies specific for chondroitin sulfate and keratan sulfate glycosaminoglycans. These stains
revealed laminitis associated dispersion of the glycosaminoglycans to the edges of the SDL in
horses presenting OG3 lameness (Fig 5.6 A-F) similar to that observed for collagen I and
fibronectin. Specificity of these stains were again confirmed by dot blotting (Fig 5.6G). In
addition, staining with hematoxylin and eosin showed that cells of the SDL are cocooned in an
amorphous ECM that completely fills the SDL in healthy horses (Fig 5.7 panels A and D), and in
horses presenting OG1 lameness (Fig 5.7 Panels B and E), but which is disrupted and absent
from regions of the SDL neighboring the primary epidermal laminae in horses presenting OG3
lameness (Figures 5.7 C and F).

5.3 Discussion
MMPs are a family of zinc-dependent endopeptidases capable of degrading essentially all
components of the ECM. They are required for physiological remodeling of the ECM in tissue
morphogenesis, growth and repair114. MMPs are dysregulated in pathological conditions such as
rheumatoid arthritis, osteoarthritis and autoimmune blistering disorders of the skin 114,118,119 and
cause pathology by excessive degradation of the ECM in these conditions. We show here that
healthy horses constitutively express genes encoding MMP-1, -3, -13, -14, -15 and -16 consistent
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with on-going dynamic remodeling of the laminae, but expression of genes encoding MMP-1
and -13 is selectively upregulated in the laminae of horses with starch-induced acute laminitis,
consistent with a contribution of the MMP to laminitis associated pathology. Upregulation of
MMP-1 gene expression occurred in the laminae of horses presenting OG1 and OG3 lameness,
whereas upregulation of MMP-13 gene expression was detected only in horses presenting OG3
lameness. Despite its upregulated expression MMP-1 is unlikely to contribute to pathologic
laminar remodeling because only putatively non-glycosylated 52kDa pro-MMP-1114,115 was
detected in extracts of laminae. In contrast, both pro- (61 kDa) and active (propeptide-free; 48
kDa) forms of MMP13114,115 were significantly increased in the laminae of horses presenting
OG3 lameness relative to that in laminae of healthy horses, raising the possibility that MMP-13
contributes to laminar pathology.
MMP-1 and MMP-13 are known to be produced by activated fibroblasts, epithelial cells and
inflammatory leukocytes in other systems114. In the case of the equine digital laminae,
immunofluorescence analyses showed that MMP-13 localizes to the basal epithelial cells which
line the junction between the epidermal and dermal laminae and which abut the SDL. Lack of an
appropriate specific antibody precluded immune-localization of MMP-1 in laminae, but expression
of the gene encoding MMP-1 has been localized to laminar basal epithelial cells by laser capture
microscopy and qRT-PCR analysis (Belknap, personal communication). Dysregulation of MMP-1
and MMP-13 therefore joins that of ADAMTS-479 as indicators of profound physiological stress in
laminar basal epithelial cells associated with the development of laminitis.
Expression and activation of MMPs are tightly controlled on several levels including
regulation of transcription, enzymatic mediated cleavage of pro-peptide and inhibition by
protease inhibitors. It has been shown that transcription factor Fos/Jun and AP-1mediate
enhanced expression of MMP-1, MMP-13 and ADAMTS-4 in response to inflammatory factors
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such as interleukin-1 and tumor necrosis factor alpha54,120 consistent with an inflammatory
component of laminitis121,122. However, while laminar inflammation and elevated ADAMTS-479
gene expression is detected as early as the developmental (fever) stage of starch-induced
laminitis, elevated laminar MMP-1 gene expression is first detected at OG1 lameness, while that
of MMP-13 gene expression becomes elevated at some (as yet unmapped) period between OG1
and OG3 lameness. Thus, the relationship between MMP-13 expression and laminar
inflammation is obscure.
MMP-13, also named collagenase-3, cleaves the triple helix of Type I, III and IV collagens,
and also cleaves fibronectin, and laminin. Cleaved triple helical collagen denatures
spontaneously at 37 °C into gelatin and is further degraded by MMP-2 and MMP-9114,115, the
former of which is significantly elevated in the laminae of horses presenting OG3 lameness
compared to those of healthy horses53. Fibronectin also plays a critical role in maintaining the
integrity of the ECM because it binds both to the extracellular domain of membrane spanning
integrins and to ECM components such as collagen and heparin sulfate proteoglycans, mediating
attachment of cells to the ECM and ECM components to each other123. Thus, elevated presence
of processed MMP-13 if accompanied by elevated substrate cleavage, would compromise the
integrity of the dermal ECM and its capacity to accommodate ambient biomechanical forces
without tearing. Consistent with this possibility, we report here that Type I collagen and
fibronectin are substantially redistributed in the secondary dermal laminae of horses presenting
OG3 lameness compared to those of healthy horses as are other ECM components, giving the
appearance of multifocal gaps or tears in the ECM. However, although we favor the possibility
that MMP-13 contributes to the development of laminar pathology, correlated events are not
necessarily causally related. Consequently, the extent to which substrate degradation by MMP13 contributes to the development of multifocal gaps in the dermal ECM remains to be
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determined, which will require selective in situ inhibition of the MMP in horses with acute
starch-induced laminitis.
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5.4 Chapter 5 Figures

Figure 5.1
Validation of qRT-PCR Primers: Lanes 1) DNA ladder, 2) MMP-1, 3) MMP-13, 4) MMP-14, 5)
MMP-16, 6) MMP-3, 7) MMP-15, 8) GapDH housekeeping gene, and 9) blank control.

76

Figure 5.2
Gene Expression of MMPs 1 and 13 in Acute Laminitis: qRT-PCR analysis of lamellar gene
expression of A) MMP-1 and B) MMP-13 in control (n=8), developmental (n=6), OG1 (n=6), and
OG3 (n=5) animals. * indicates p<0.05, ** indicates p<0.01.
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Figure 5.3
Increase in protein expression of MMP-1 and MMP-13: Western blot analysis of protein
expression of MMP-1 A) and MMp-13 B) in lamellar extracts from control (n=8), OG1 (n=6), and
OG3 (n=5) animals. Box signifies common sample run in all three gels to normalize
experimental variation between gels. 52kDa band corresponds to the pro-form of MMP-1 and
61kDa band corresponds to the pro-form of MMP-13 while 48kDa band corresponds to the
active form of MMP-13..* indicates p<0.05, ** indicates p<0.01.
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Figure 5.4
Distribution of MMP-13 and its Substrates in the Secondary Dermal Lamellae:
Immunofluorescent staining (red) of MMP13 (A-C), collagen type I (D-F) and fibronectin (G-I) in
tissue sections from control (n=6), OG1 (n=6), and OG3 (n=4) animals. Representative images
shown. Autofluorescent collagen shown in green, nuclei in blue. Scale bars 50μm.

-
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Figure 5.5
Validation of Collagen and Fibronectin Antibody Specificity: 1μg purified collagen type I or 1μg
purified fibronectin were blotted in duplicate onto PVDF membrane then incubated with a
1:1000 dilution of anti-collagen I or anti-fibronectin (Appendix C) and a subsequent 1:10,000
dilution of rabbit anti-mouse IgG-HRP
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Figure 5.6
Loss of Glycosaminoglycans from the SDL during CHO-induced laminitis. Keratan sulfate (A)
and chondroitin-6-sulfate (D) were localized, in red, to the dermal lamellae of healthy animals by
immunofluorescent staining subsequent to 30 minute epitope-revealing digestion. No staining
was noted for either antibody in the absence of digestion (B,E). At OG3 stage disease, there was
marked loss of both materials in the SDL (C,F). Autofluorescent collagen and keratin visualized in
green (A-E), basement membrane visualized by staining against laminin in green (F), nuclei
stained blue. Scale bars 50µm, representative images shown. G) Antibody and digestion
specificity were determined by dot blotting. 5µg of NP-40 extracted material was digested at
37ºC for 30 minutes with either 0.01 Units of Chondroitinase ABC in a pH 8.0 buffer or 0.01
Units of Keratanase in a pH 7.4 buffer then blotted onto a PVDF membrane.. The membrane
was then incubated with a 1:1000 dilution of antibodies against chondroitin-6-sulfate or keratan
sulfate followed by a 1:10,000 dilution of rabbit anti-mouse IgG-HRP.
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Figure 5.7
Complete Loss of All ECM Elements in the SDL in OG3 Laminitis. Hematoxylin and eosin
staining of 10μm sections of a representative animal from A) and D) control group, B) and E) OGI
group, and C) and F) OGIII group. Scale bars 50μm.
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CHAPTER 6
DISCUSSION AND FUTURE DIRECTIONS: HOW DO THE MARKERS OF ACUTE CHO-INDUCED
LAMINAR PATHOLOGY HOLD UP IN OTHER MODELS AND CLINICAL CASES?

6.1 Introduction
The previous chapters have described in detail several biomolecular hallmarks of the
pathogenesis of laminitis in a carbohydrate-induced model: increased expression of ADAMTS-4,
decreased expression of versican and the canonical wnt signaling pathway, and increased
expression of MMP-1 and -13. However, in order to draw conclusions from these data that
could lead to clinically relevant therapies, it is necessary to determine the expression of these
markers in other models of disease as well as clinical samples. To address this, we were granted
access to the Laminitis Discovery Database tissue repository at the University Of Pennsylvania
School Of Veterinary Medicine124, and were able to compile sample cohorts from two additional
induction methods, oligofructose (OF)8 and hyperinsulinemia (HI)125, and from animals
presenting to the university veterinary hospital with naturally developed disease. The clinical
samples were organized into two groups, those animals with supporting limb laminitis (SLL) and
those with chronic laminitis, who were suspected to have developed laminitis secondary to
endocrinopathic dysfunction.
The model of alimentary carbohydrate overload utilized in these studies has been in practice
for a number of years. The CHO starch gruel model was developed in 1975 to mimic accident
ingestion of excess grain6. More recently, the OF model was developed to mimic laminitis
associated with overgrazing of lush pasture grass8. Grazing pasture grasses with high
concentrations of the non-structural carbohydrate, fructan, have been associated with
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increased incidence of laminitis, and accidental overgrazing, particularly in the spring and
summer months, are a leading identifiable “cause” of clinical presentations of laminitis 126.
Endocrinopathic laminitis is a term that encompasses those cases where laminitis develops
secondary to either equine pituitary pars intermedia dysfunction (PPID), also known as equine
Cushing’s disease, or equine metabolic syndrome (EMS)127,128. These conditions are most
commonly associated with chronic disease. A unifying feature of these metabolic disorders is
the development of insulin resistance, resulting in serum hyperinsulinemia. To model this,
administration of a constant infusion of insulin through a prolonged euglycemichyperinsulinemic clamp (p-EHC) has been developed125. A drawback of this model, however, is
the fact that the p-EHC clamp induces acute laminitis, while endocrinopathic laminitis may
clinically develop more slowly, over the course of months or years.
Supporting limb laminitis, while perhaps not as common as the other forms of laminitis, has
a mortality rate of at least 50%129. Caused by unequal weight bearing on one limb, frequently
due to an injury of the contralateral limb, SLL is often characterized by a rapid and severe failure
of the laminae130. Indeed, the animals used in this study that were ultimately euthanized for SLL
were all thoroughbred racehorses that experienced some sort of racetrack breakdown to the
limb opposite the laminitic hoof. Presently, the majority of literature concerning SLL consists of
retrospective studies and gross pathological and biomechanical analyses. There is little to no
molecular data concerning the pathogenesis of this type of laminitis. However, because many
cases of SLL develop during hospitalization131, these animals are prime candidates for targeted
therapies to prevent the development of laminitis.
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6.2 Sample Cohorts
6.2.1

Hyperinsulinemia Induction
Healthy Standardbred horses were assigned to either control or treatment groups.

Horses were fitted with a prolonged euglycemic-hyperinsulinemic clamp (p-EHC) to facilitate
insulin infusion as described125. Horses were treated with an initial bolus (45miu/kg body
weight) of insulin followed by a continuous infusion of insulin (6miu/kg/min) and 50% glucose
solution. Sham-treated control animals (n=4) received infusions of a balanced electrolyte
solution. Horses were euthanized at 24 hours (n=4) or at the onset of OG2 lameness (46±2.31
hours; n=3). The hooves of the animals were detached at the metacarpophalangeal joint and
lamellar tissue dissected. Blocks of lamellar tissue (5mm x 5mm) were flash frozen in liquid
nitrogen and maintained at -80°C until use. Animals were housed at the University of
Queensland, Brisbane, Queensland, Australia, and the experimental protocol approved by the
University of Queensland Animal Ethics Committee in compliance with the Animal Welfare Act
of Queensland (2001).

6.2.2

Oligofructose Induction
Healthy Standardbred horses were assigned to either control or treatment groups.

Animals were dosed with 10g/kg body weight of oligofructose (Raftilose P-95) dissolved in 4L of
water via nasogastric tube or 4L or water as a control, as described8. Animals were euthanized
at 24 hours (n=6 control; n=6 treated). Blocks of lamellar tissue were dissected from the
disarticulated right front hoof, as described above, flash frozen in liquid nitrogen and stored at 80°C until use. This experiment was also performed under the auspices of the University of
Queensland in accordance with the Animals Welfare Act of Queensland (2001) and approved by
the University of Queensland Animal Ethics Committee.

85

6.2.3

Clinical Supporting Limb Laminitis Samples
7 horses were diagnosed with supporting limb laminitis secondary to injury in the

contralateral limb and subsequently euthanized at the University of Pennsylvania School of
Veterinary Medicine New Bolton Center124. The cohort consists of 6 thoroughbreds and 1
warmblood; 5 mares, 1 gelding, and 1 intact male; ranging in age from 2-10 years old. After
owner consent, the affected hoof was disarticulated at the metacarpophalangeal joint,
sectioned with a band saw, and segments of laminae dissected and flash frozen in liquid
nitrogen. Samples were stored at -80°C until use.

6.2.4

Clinical Chronic Endocrinopathic Laminitis
7 horses presented with chronic laminitis to the University of Pennsylvania School of

Veterinary Medicine New Bolton Center and were subsequently euthanized124. The cohort
consists of 3 Morgans, 1 Quarter Horse, 1 warmblood, 1 Welsh Pony-Thoroughbred cross, and 1
miniature horse; 3 mares, 3 geldings, and 1 intact male; ranging in age from 8 to 33 years old. 2
of the animals had been diagnosed with PPID, while the remainder displayed phenotypic
indicators of EMS, including obesity. Estimated duration of “chronic” laminitis ranged from 2
months to greater than 5 years, according to owner-dictated history. After owner consent,
blocks of lamellar tissue were harvested from the front and hind feet, snap frozen in liquid
nitrogen, and stored at -80°C until use. In addition, laminar samples from 8 animals euthanized
for reasons unrelated to lameness or laminitis were harvested using identical protocols and
utilized as a control cohort for analysis of both the SLL and Chronic samples.
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6.3 Preliminary Data
qRT-PCR analyses revealed significant upregulation of ADAMTS-4, MMP-1, and MMP-13 in
both the acute HI and OF induced samples (Fig 6.1 A and B). In the HI samples, these genes
were not significantly upregulated until the 48 hour, or OG2, timepoint, while in the OF samples,
these genes were elevated at 24 hours. The increased expression of MMP-13 in the OF 24 hour
timepoint is also in constrast to the CHO model described in Chapter 5, which did not see
increased MMP-13 gene expression until OG3 stage disease. In the clinical samples, only MMP13 was significantly elevated in either the Chronic or the SLL animals (Figure 6.1 C and D). In the
Chronic cohort (Figure 6.1 C), the highest data point in each of the graphs corresponded to a
single animal, and, similarly, a single animal was responsible for the highest relative gene
expression of MMP-1 and -13 in the SLL cohort (Figure 6.1 D).
Canonical wnt signaling pathway was significantly down regulated in the HI and Chronic
groups (Figure 6.2 A and C). Interestingly, there was no decrease in wnt pathway members in
the OF model (Figure 6.2 B), and a slight increase in wnt4 gene expression. While the wnt
pathway culminating transcription factor, TCF4, was significantly downregulated in SLL laminitis,
along with the wnt signaling receptor frizzled 4, in SLL laminitis (Figure 6.2 D), neither versican,
β-catenin, nor wnt4 displayed differential expression between control and laminitic tissues.
Expression of the hemidesmosome components, integrins α6 and β4, was likewise
diminished in the HI and Chronic groups (Figure 6.3 A and C). The OF samples had a slight but
significant increase in expression of integrin α6 (Figure 6.3 B), while there was a significant
decrease in integrin β4 expression in the SLL animals (Figure 6.3 D).
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6.4 Discussion
Screening for gene expression of markers we have determined to be hallmarks of laminar
pathology in a carbohydrate induction model, namely versican and members of the wnt
signaling pathway, ADAMTS-4, MMPs 1 and 13, and hemidesmosomal integrins, in additional
models and clinical cases of laminitis provides a great measure of context in which to place our
previous findings. This context may give important insight into the pathogenesis of laminitis,
irrespective of origin. To that end, the similarity in differential gene expression patterns
between the CHO, HI, and Chronic samples is striking. In terms of versican, the wnt signaling
pathway, and integrin β4, the animals in the HI and Chronic group had identical expression
patterns to those we have seen in the CHO group. It is therefore possible that systemic insulin
levels may play a heretofore unappreciated role in CHO-mediated laminar pathology.
Hyperinsulinemia has long been recognized as a risk factor for development of laminitis.
Increased circulating insulin can be caused by multiple conditions, including obesity, PPID,
corticosteroid administration, and equine metabolic syndrome (EMS), which is a disease
characterized by insulin resistance (IR), regional adiposity, and recurring laminitis 125,127,128. The
mechanism by which insulin may be causing laminitis, however, remains unclear. Studies have
been undertaken to discern the role of glucose transport132-134, digital perfusion or
vasoconstriction135,136, inflammatory cytokines137-140, and various metalloproteases141 in HI
induced and IR animals, with varying and ultimately inconclusive results. Addionally, the insulin
receptor has only recently been localized within the laminae, and it was found to be expressed
only in endothelial cells of the dermal lamellae142. However, insulin-like growth factor 1
receptors (IGF-1R) were localized to the epithelium of the secondary epidermal lamellae as well
as in cells morphologically consistent with fibroblasts in the dermal lamellae142. Insulin has been
demonstrated to have the ability to signal through IGF-1R, particularly in incidences of insulin
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concentrations above physiologically normal143. Additionally, gene expression of IGF-1R was
found to be downregulated in HI laminitis, which is consistent with hyperstimulation of the
receptor, but without a corresponding increase in serum IGF-1144. The extent to which IGF-1R
may have a role in regulating the canonical wnt signaling pathway, however, is unclear. Insulin
signaling through the insulin or IGF-1 receptors is known to interface with the wnt signaling
pathway at the level of the LRP5 and LRP6 co-receptors103,145, and IGF-1 signaling has been
shown in Xenopus development to suppress wnt signaling between β-catenin and TCF146.
Additionally, CHO induction has only shown a transitory serum insulin spike, which returned to
baseline by 6 hours after induction147, so further investigation is warranted to determine the
specific serum concentration and duration of hyperinsulinemia that may be required to
stimulate the IGF-1R signaling pathway.
Even less clear is the relationship, if any, between metalloprotease expression and
insulin. As stated previously, various metalloproteinases have been studied in the development
of laminitis secondary to HI induction or in IR animals. MMPs 1, 2, MT1-MMP, and TIMP-3 were
not found to be differentially regulated during laminitis141. Additionally, ADAMTS-4 was found
to not be increased during HI induction, which directly contradicts the data presented above 141.
In that particular study, however, changes in gene expression of ADAMTS-4 may have been
obscured by the use of primers that did not amplify across an intron, and warrants further
investigation. Interestingly, in human chondrocytes, signaling through IGF-1R has been found to
down regulate expression of MMP-13 at both the gene and protein level, perhaps through
either NF-κB148 or ERK149 regulation. It is therefore possible that metalloprotease expression,
particularly MMP-13, could be a pathophysiological process operating independently yet
concurrent with the dysregulation of the wnt signaling pathway. This is further indicated by
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increased gene expression of ADAMTS-4 and MMPs 1 and 13 in both the OF and SLL cohorts,
independent of differential expression of hemidesmosomal or wnt pathway genes.
To that end, the increased expression of MMP-13 across all cohorts provides what could
be another crucial contextual clue about the development of laminitis. With the exception of
the OF group, MMP-13 expression is upregulated later in disease development. A potential
common feature of all sample groups at that point in pathogenesis is biomechanical stretch, as
the hemidesmosome and adherens junctions of the epithelium have ostensibly begun to fail in
the CHO, HI, and Chronic groups, and the laminae is, by definition, unduly loaded in SLL. Indeed,
compression has been shown to induce MMP-13, MMP-2, and MMP-9 gene expression in
murine costal cartilage explants150. ADAMTS-5 and MMP-13 gene expression was also found to
be increased after cyclic tensile strain in sw1353 chondrosarcoma cells 151. Seeing as MMP-13
expression can also be induced by fibronectin fragments148, it is possible that the mechanical
strain of late-stage laminitis could trigger a catastrophic positive feedback loop of MMP-13
expression and activation. It is also worth noting that, in human pre-osteoblasts, episodes of
mechanical stretching resulted in down regulation of wnt and β-catenin signaling, which could
be rescued, at least in terms of cytosolic β-catenin, by lithium chloride pre-treatment152.
It is interesting to note the differences in gene expression in the OF induction versus the
CHO. The oligofructose model was developed to be, in effect, another carbohydrate overloadbased induction, but instead using non-structural carbohydrates similar to those found in
pasture grass8. However, these samples were collected according to a strict time course postadministration of OF and not according to a set lameness score, in an effort to use the samples
to identify early instigators of disease. As such, the samples we were able to obtain, collected at
24 hours, were in fact collected before the clinical onset of lameness, which in another study by
the same group was found to occur at 28 ± 1.83 hours after induction 138. It is therefore not
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entirely surprising that ADAMTS-4, which is highly upregulated early in the development of CHO
laminitis19, is likewise upregulated in an apparently early timepoint in OF induction. ADAMTS-4
has also been found to be upregulated at 24 hours by the group who generated the samples;
however, as stated above, their primers may be suspect. It is possible that, given samples taken
at later timepoints or organized by lameness score and not by time, we would be able to see
more similarity between the carbohydrate induction methods. The difference between the time
from induction to onset of lameness between the CHO and OF models may well be due to
differential fermentation of the carbohydrates by the flora of the hindgut. Studies in swine have
linked increased volatile fatty acid (VFA) production and increased insulin production 153,154. As
horses derive a good portion of their metabolic energy from post-gastric fermentation, it could
be beneficial to pursue characterizing the VFA profiles generated by each of these
carbohydrates.
Taken together, these data aid in hypothesizing a sequence of events in the
development of carbohydrate or insulin-induced laminitis, illustrated in Figure 6.4. In the case
of carbohydrate overload, the hindgut is flooded with excess starch, favoring those bacterial
species that utilize starch as a substrate. These conditions lead to an overgrowth of those
species, to the detriment of other intestinal flora155. What remains unclear is if glucose itself is
leaking out of the digestive tract, or if there may be some as yet unidentified toxic bacterial
byproduct that is being released as a result of the unbalanced bacterial populations. Based on
the data from the HI and Chronic tissue cohorts, we hypothesize that carbohydrate overload
would lead to increased serum insulin. While, as stated above, there has not been clear
identification of the insulin receptor in laminar tissue, IGF-1R has been localized to the basal
epithelium of the secondary epidermal lamellae142, and this receptor was downregulated in the
HI model, suggesting that insulin may be signaling through this receptor144. IGF-1R signaling has
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been shown to activate AKT156, which in turn phosphorylates GSK3β88, thus sustaining the
canonical wnt signaling pathway. Loss of signaling through this receptor could be a mechanism
of the loss of canonical wnt signaling seen in the carbohydrate model, which results in loss of βcatenin protein expression and thus loss of adherens junctions and cell:cell attachment.
Correlated with the loss of β-catenin is the loss of the hemidesmosome protein integrin β4, as
demonstrated in Chapter 4. Carbohydrate overload has also been demonstrated to cause an
increase in pro-inflammatory cytokines, particularly IL-1β157,158, which is a known inducer of
ADAMTS-4159. The upregulation of ADAMTS-4 in the carbohydrate model was shown in Chapter
3 to lead to increased versican cleavage. We hypothesize that these two pathways, the
upregulation of ADAMTS-4 and suppression of canonical wnt signaling, are happening
concurrently, and ultimately result in the weakening of the epidermal lamellae due to loss of
cell:cell and cell:basement membrane attachments, as well as the loss of proteoglycan structure
within the cell. Due to the biomechanical stressors on the tissue, namely, weight bearing and
the rotational force of the deep digital flexor tendon, the laminae then begin to experience
increased stretch as the basal epithelial cells fail. This results in the upregulation of MMP-13
and subsequent redistribution of its substrates collagens I and III and fibronectin in the dermal
lamellae, as demonstrated in Chapter 5. This timeline is supported by the data presented in
Chapter 5 showing increases in MMP-13 at the later stages of disease. Thus, carbohydrateinduced laminitis is ultimately caused by a combination of loss of the anchoring proteins holding
the basal epithelium together, activation of two specific metalloproteinases, and biomechanical
failure.
In summary, the data presented in this dissertation provide a detailed characterization
of the molecular pathophysiology of equine laminitis in a carbohydrate induction system, and
provide some clues as to potential systemic instigators of disease. Going forward, these data
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also highlight a critical need for an in vitro cell culture system to answer the lingering questions
of what exact signaling pathways are involved in laminar pathogenesis and how they interact.
Retrospective studies undertaken on tissue harvested at specific time points or from clinical
cases are not sufficient to elucidate these mechanisms. Studies have been performed in laminar
epithelia holoclone cultures, however, these culture systems present numerous technical
difficulties, not limited to the need for a layer of feeder cells, the need for extensive
supplementation of growth factors, and the technical challenges of obtaining a continual source
of cells and isolation. Sorting out the potential interplay between insulin, wnt signaling, and
mechanical strain in such a system would also aid in providing a timeline of pathogenesis which
would further aid in designing targeted clinical therapies.
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6.5 Chapter 6 Figures

Figure 6.1
Gene Expression of Versican and the Wnt Signaling Pathway: qRT-PCR gene expression
analysis in samples from A) hyperinsulinemia induced animals, B) oligofructose induced animals,
C) animals euthanized due to chronic endocrinopathic laminitis, and D) animals euthanized due
to supporting limb laminitis.
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Figure 6.2
Gene Expression of ADAMTS-4, MMP-1, and MMP-13: qRT-PCR gene expression analysis in
samples from A) hyperinsulinemia induced animals, B) oligofructose induced animals, C) animals
euthanized due to chronic endocrinopathic laminitis, and D) animals euthanized due to
supporting limb laminitis.
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Figure 6.3
Gene Expression of Hemidesmosomal Integrins: qRT-PCR gene expression analysis in samples
from A) hyperinsulinemia induced animals, B) oligofructose induced animals, C) animals
euthanized due to chronic endocrinopathic laminitis, and D) animals euthanized due to
supporting limb laminitis.
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Figure 6.4
Model of the series of events leading to failure of the digital laminae in carbohydrate and
insulin induced laminitis
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APPENDIX A
MATERIALS AND METHODS

Animals, Tissue Collection, and Immunization
Horses
Front hoof laminae were collected from 8 healthy horses as previously described 53,113.
Briefly, healthy horses were placed under general anesthesia, their distal right forelimbs
detached at the metacarpophalangeal joint and the animals euthanized immediately thereafter
under protocols approved by the IACUC of the University of Missouri College of Veterinary
Medicine. Excised hoofs were sectioned using a band saw and segments of lamina
(approximately 5 mm x 5 mm x 5 mm) spanning from the inner hoof wall to the outer face of the
distal phalanx were dissected using a sharp scalpel and flash frozen in liquid nitrogen for
molecular and biochemical analyses. For immunofluorescent microscopy, segments were
embedded in a commercial preparation of water soluble glycols and resins a and frozen over dry
ice (6 of the 8 laminae only). All segments of laminae were processed or frozen within 5
minutes of detachment of the distal right forelimb.

Rabbits
Two female New Zealand White rabbits were immunized with an equine ADAMTS-4specific peptide (described below) conjugated to keyhole limpet hemocyanin (KLH) and
emulsified in an adjuvantb1. Briefly, each rabbit received 500 µg protein dispersed over 10 sites
on the back and was boosted three times over the course of 10 weeks with an additional 250 µg
peptide-KLH emulsified in an adjuvantb2. The animals were exanguinated 10 days after the last
immunization, blood collected for serum preparation and serum stored at -20oC until use. All
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procedures were carried out under protocols approved by the IACUC of the University of
Massachusetts. The peptide, “NTPEDSDPDHFD,” corresponded to amino acids 300-311 of the
equine ADAMTS-4 sequence and was synthesizedc with an N-terminal cysteine residue to
facilitate conjugation to the KLH. The peptide was chosen from an area of ADAMTS-4 predicted
to be a loop structure in the metalloproteinase domain based on homology to the human
protein sequence, for which the crystal structure has been solved. Peptide specific antibody
was affinity purified from rabbit serum using sepharose beads d conjugated to the
“NTPEDSDPDHFD” peptide. The concentration of purified antibody was determined by
spectrophotometrye.
RNA
RNA was collected from three separate sections of dorsal lamina from each horse using
an RNA extraction kitf1. Briefly, flash frozen tissue was pulverized in a pre-chilled (on dry ice)
slammerg and homogenized in the lysis buffer provided, then passed through the column
provided and washed accordingly. The purity and concentration of RNA were determined e and
extracted RNA was used for cDNA preparation only when the A260:A280 and the A260:A230
ratios were very close to 2.0. Integrity of isolated RNA was confirmed by electrophoresis on a
1.0% agarose gel and staining with a proprietary polynucleotide gel stain h.
cDNA was synthesized from isolated RNA using a cDNA synthesis kiti.
PCR
Relative Quantitative Real Time PCR
Primer sets were generated against the equine sequence (Appendix B). GAPDH was
employed as a housekeeping gene using primers previously described 19. Briefly, RT-qPCR
reactions were run using a proprietary reaction mixture which contains a high performance
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reverse transcriptase and reference dyes j according to manufacturer’s instructions and data
were read with a thermal cyclerf2 as described19.
Non-Quantitative PCR
Specific cDNA fragments of four versican isoforms (V0, V1, V2 and V3) were amplified by
PCR160 using the primers listed in Appendix B. All amplifications were performed for 35 cycles
following the conditions: 94°C for 2min, 94°C for 30s, 58°C for 30s, 72°C for 1min and 72°C for
7min using a PCR thermal cyclerk PCR products were visualized after electrophoresis on a 2.0%
agarose gel by staining with a proprietary polynucleotide gel stainh, and bands were excised,
purified, and sent for sequence confirmation.
Protein Extracts
NP-40 Soluble Material
~ 0.35g snap frozen segments of dorsal laminae was pulverized in a pre-chilled (on dry
ice) slammerg and immediately homogenized in 10ml of extraction buffer (50mM Tris pH7.0, 150
mM NaCl, 5mM ethylenediaminetetraacetic acid, 0.5% NP-40 containing 10μM E64, 1.5μM
pepstatin A and 1 mM phenylmethanesulfonyl fluoride) on ice. The homogenized sample was
incubated overnight at 4°C, centrifuged (14,000 g) 15 min in 4°C, supernatant collected and
protein in the supernatant precipitated by addition of ice cold absolute ethanol to a final
concentration of 80% v/v. The precipitate was washed with ice cold 80% ethanol twice, dried
under nitrogen and dissolved in PBS. Protein concentration was determined by a colorimetric
assay based on a protein binding dyel1.
Guanidine Hydrochloride Soluble Material
～0.35g snap frozen segments of dorsal laminae was pulverized in a pre-chilled slammer
and homogenized in 5ml of cold extraction buffer (0.1 M PBS, with 5 mM iodoacetic acid,
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0.1 mM 4-(2-aminoethyl) benzenesulphonyl fluoride, 1% 3-[(cholamidopropyl)dimethylammonio]-1-propane-sulfonate, 1 µg/ml pepstatin A, 50 mM sodium acetate, 5 mM
benzamidine hydrochloride hydrate, 5 mM phenylmethylsulfonyl fluoride, 10 mM Nethylmaleimide, 4 M guanidine hydrochloride, pH7.6) [additionally supplemented with a
proteinase inhibitor cocktailb3] for 30 sec on ice and extracted overnight (~15 hours) at 4°C. The
samples were centrifuged at 14,000 g for 30 min at 4°C, a ﬂoating layer of insoluble lipids
removed and the remaining supernatant collected and precipitated overnight with 4 vol. of ice
cold absolute ethanol containing 5 mM sodium acetate. Precipitated molecules were collected
by centrifugation at 4°C for 1 hr at 14,000g, dried under nitrogen and the pellet was resuspended in buffer and digested with 0.06 Units Streptomyces hyaluronidasem/10µg weight of
original frozen tissue as described by the manufacturer. After digestion the supernatant solids
were precipitated by addition of ice cold absolute ethanol containing 5mM sodium acetate to a
final concentration of 80% v/v as above, dried and digested with 0.01 Units Chondroitinase
ABCn/10µg weight of original frozen tissue as per manufacturer’s instructions. Supernatant
solids were again precipitated and dried as above and digested with 10 µUnits Keratanase
IIn/10µg weight of original frozen tissue. The above digestion protocol allowed solubilization of
the many molecules that form insoluble macromolecular complexes with hyaluronan and their
subsequent analysis by SDS-PAGE.
SDS-PAGE and Western Blotting
An aliquot (30 μg protein content) of extract was boiled in reducing Laemmli (5 mM 2mercaptoethanol) sample bufferl2 for 5min and subjected to SDS-PAGE in a 4% (w/v)
polyacrylamide stacking gel with a 10% (w/v) polyacrylamide gel as previously described 161.
Proteins were transferred to polyvinylidene fluoride membranes by electroblotting. The
membrane was blocked with 5% dry milk in PBS with 0.05% tween-20 for 1 hr, washed with PBS
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with 0.1% tween-20 for 30 min and then incubated with primary antibodies overnight at 4°C
(Appendix C). After incubation with primary antibodies the membranes were washed twice in
PBS with 0.1% tween-20 for 30 min and incubated with secondary antibodies conjugated with
horseradish peroxidase (Appendix C). Detection was performed using enhanced
chemiluminescencel3 visualized with a gel imaging and documentation systemo1 and
quantification was done using associated softwareo2.
Immunofluorescence
Frozen sections (10 μm thick) were cut from embeddeda tissues and affixed to treated
glass slidesp. Immunofluorescent staining was carried out using methods previously
described162. Briefly, slides were blocked with 5% BSA in PBS with 0.001% tween-20 and treated
with optimal dilutions of primary antibodies, described in Appendix D, for one hour at room
temperature. Sections were washed and treated for one hour at room temperature with
secondary antibodies along with a 1:2000 dilution of DAPI. Actin was visualized by incubating
tissue sections with a 1:200 dilution of phalloidin-FITCb4 conjugate for one hour at room
temperature.
Specificity of staining was established using enzyme digestion and peptide blocking. Enzymatic
digestions were carried out for one hour at 37°C as follows: i) for destruction of hyaluronan
epitopes, sections were treated with 0.01Units of chondroitinase ABCb5 in 20 µl 50mM Tris pH
6.8 and 60mM sodium acetate with 0.2% BSA. After digestion, sections were thoroughly
washed with PBS with 0.001% tween-20, and reacted with antibodies as described above. ii) For
peptide competitions, antibodies were incubated overnight with a 10 fold excess of cognate
peptide or antisense peptide in 1% BSA at 4°C prior to incubation with sections as described
above. All slides were imaged using an inverted microscope with apotome grid, UV, blue and
green excitation light and 20x or 63x objectives q1.
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Hematoxylin and Eosin Staining
10μm sections of unfixed, frozen tissue from a representative control, OGI and OGIII
animal were dehydrated in ethanol and progressively rehydrated through several changes of
solution and stained with Gill’s hematoxylin #3 and a 0.5% alcoholic solution of eosin Yb. Slides
were imaged on a standard light microscope.
Quantitation of Tissue Immunofluorescence
Average fluorescence was calculated using commercially available softwareq2. The basal
epithelia were traced from crypt to tip of the secondary epidermal lamellae and average
fluorescence intensity values calculated for the red channel in the enclosed area. A total of 60
measurements were taken for each animal, from n=6 control, n=6 OG1, and n=4 OG3 animals.
Statistics
Gene and Protein Expression
Statistical analyses of gene expression and western blot data were performed using
commercial softwarer. For RT-qPCR and Western blot results comparisons, the normalized
values from each horse were analyzed by using the 1-way ANOVA with Dunnett's post test. In
cases where data were not distributed normally, a Kruskal-Wallis ANOVA with Dunnett’s post
test or Mann-Whitney test were used as appropriate. Pearson product moment correlation coefficient analyses with two-tailed 95 % confidence were performed in pairs of expressed
Western blot bands. Pearson’s r values can range between -1 and +1 denoting the degree of
positive or negative correlation between paired data, with a P value of 0.05 being considered
significant. The square of Pearson’s r value (r 2) denotes (explained variance) ÷ (explained
variance + unexplained variance).
Protein Distribution
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Analysis of immunofluorescence data was performed using a 2-way ANOVA with a
Duncan’s post test using a commercially available specialized statistical package s.

Product Information
a. Tissue-Tek O.C.T.; Sakura Finetek USA, Inc., Torrance, CA
b1. Freund’s adjuvant, complete; b2. Freund’s adjuvant, incomplete; b3. Sigma Fast Protease
Inhibitor Cocktail; b4. Phalloidin-FITC; b5. Chondroitinase ABC; Sigma-Aldrich, St. Louis, MO
c. GenScript USA, Inc., Piscataway, NJ
d. NHS-Activated Sepharose Fast Flow Beads, GE Healthcare Biosciences, Pittsburgh, PA
e. NanoDrop 1000; Thermo Scientific, Wilmington, DE.
f1. Stratagene Absolutely RNA kit; f2. Stratagene MX 3005p; Stratagene, La Jolla, CA.
g. Biospec Products, Inc., Bartlesville, OK
h. SYBRSafe DNA Gel Stain; Molecular Probes, Eugene, OR.
i. Quanta q Script cDNA Synthesis Kit; Quanta BioSciences, Gaithersburg, MD
j. SYBR Premix Ex Taq; Applied Biosystems, Foster City, CA.
k. PTC-100PCR System; MJ Research Inc., Waltham, MA
l1. Bradford Assay; l2 Laemmli Reducing Sample Buffer; l3 E.C.L; Bio Rad Life Sciences, Hercules,
CA
m. Calbiochem, EMD, Merck KGaA, Darmstadt, Germany
n. Seikagaku, Tokyo, Japan.
o1. G : Box ; o2. Gene Tools ; Syngene, Frederick, MD
p. Fisher Superfrost Plus ; Fisher Scientific, Fair Lawn, NJ
q1. Zeiss MOT200 with Zeiss Apotome ; q2. Axiovision version 4.6.3.0 ; Carl Zeiss MicroImaging,
Inc., Thornwood, NY
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r. GraphPad Prism Version 5 ; GraphPad Software, San Diego, CA
s. Proc GLM ; SAS Version 9.2 ; SAS Institute, Cary, N
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APPENDIX B
PRIMERS UTILIZED FOR RT-PCR AND QRT-PCR

Name

Sequence (F - forward 5'; R - reverse 5')

GenBank ID

Amplicon Length
(bp)

Efficiency

R2

ADAMTS-4
C-terminal

F-GCGTGGGCTACTATTATGTGCTG-3’
R-CCACATTGTTGTATCCGTACCT-3’

100033914

227

104%

0.976

ADAMTS-4
N-terminal

F-CAGTATCGAGGGGACCGAACT-3’
R-GAAATGCTGCCATCTTGTCAT-3’

100033914

241

93%

1.000

Aggrecan

F-CAACAACAATGCCCAAGACTAC-3’
R-AGTTCTCAAATTGCAAGGAGTG-3’

100033876

110

102%

0.981

Akt2

F-AGGACCCCATGGACTACAAGT-3’
R-CCAGGAGTTTGAGATAGTCGAA-3’

100064671

126

95%

0.990

APC

F-GACCAGAAGGCAATTGGAATA-3’
R-GGACTGCAAAAGCTGTCGTAT-3’

100064431

160

99%

0.980

Axin1

F-GATCTTCCGGGACAAAGAAG-3’
R-GCATGGTAGGGTCTTGAATGA-3’

100055241

147

99%

0.980

β-catenin

F-CCCTGAACTGACAAAACTGCTA-3’
R-AATAGCAGACACCATCTGAGGA-3’

100055241

136

98%

0.990

106

CKIα

F-TTGGGCGTCACTGTAATAAGTT-3’
R-GCAGTGCCAGTGAGATTTTTAT-3’

100060556

118

96%

0.990

Dsh

F-ACAACGAGACCAGCACAGAGT-3’
R-GTGTTGTCATCCTCGTCTGAGT-3’

100147200

205

101%

0.990

E-Cadherin

F-CATTGTGTACTCCATCCTCAGC-3’
R-TGTACTTAAGCCCTCACCTTGA-3’

100066844

175

99%

0.990

FZD4

F-CTGCTGTTGCTGTTGCTACTC-3’
R-GATGAGAGGCGTGAAAGTTGT-3’

100050464

189

96%

0.980

GSK3β

F-ATCTGCCATCGGGATATTAAAC-3’
R-ATACGAAACATTCGGTTCTCCT-3’

100061033

120

102%

0.970

Hyaluronan Synthase II

F-CACAGACAGGCTGAGGACAA-3'
R-ACAGGCTTTGGATGATGAGG-3'

100009708

231

94%

0.930

Integrin α6

F-AGTCTGCACATCTTCTTCCTGA-3’
R-CGCTCCAATCACTATATCTTGC-3’

100064056

122

100%

0.990

Integrin β4

F-GATGTGAATGAGTTCCGGAGT-3’
R-GTCAGCCTCGTAGTGGAAGG-3’

100051679

183

100%

0.990

LRP6

F-GCCAAATGGACTAACTTTGGAT-3’
R-GTGTCCTCAAATAACGTCAAGG-3’

100063409

159

102%

0.990

107

MMP-1

F-ATAACTACGATTCGGGGAGAAG-3’
R-TCTATGGGAAACCTCATAAGCA-3’

100033896

153

104%

0.970

MMP-3

F-CTTTTGATGGACCTGGAAAAGT-3’
R-GAGTGATAGAGACCCAGGGAAT-3’

100034159

169

91%

0.980

MMP-13

F-GTCCCTGATGTGGGTGAATAC-3’
R-ACATCAGACCAAACTTTGAAGG-3’

100009711

152

93%

0.990

MMP-14

F-GTTCCTGATAAGCCCAAAAACC-3’
R-CTTCCTCTCATAGGCAGTGTT-3’

14954103

213

104%

1.000

MMP-15

F-TTTTCAAAGGTGACCGCTACT-3’
R-GTCCTCTTGGAAGAAGAAGGTG-3’

100062872

158

103%

0.990

MMP-16

F-TGGTTACAAAAGTACGGCTACC-3’
R-CCTCTTGTCTGGTCAGGTACAC-3’

100049862

191

92%

0.980

PP1

F-AAAACCTTCACCGACTGCTT-3’
R-ATACGCCGAATCTGTTCCAT-3’

100059233

119

97%

0.990

TCF4

F-TTCTTTCAGCCAACAGACATTC-3’
R-AGTTGCAGACTGGACAGGAAG-3'

100049930

128

101%

0.990

Versican

F-CCTGCAATTACCATCTCACCTA-3’
R-CAGGGAGTTGATTTCATAACGA-3’

100065275

122

92%

0.990
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Versican
V0 Isoform

F-TGGTGAAGAAACAACCAGTG-3'
R-AGTGGTGACTAGATGTTTCC-3'

100065275

530

N/A

N/A

Versican
V1 Isoform

F-GCTGAAGAAGAGTGTGAAAA-3'
R-AGTGGTGACTAGATGTTTCC-3'

100065275

520

N/A

N/A

Versican
V2 Isoform

F-CTCGTGTTCCTCCCACTACC-3'
R-TGGGCAAAGTACTTGTAGCA-3'

100065275

510

N/A

N/A

Versican
V3 Isoform

F-GCTGAAGAAGAGTGTGAAAA-3'
R-TGGGCAAAGTACTTGTAGCA-3'

100065275

547

N/A

N/A

Versican
G1 Domain

F-TTATGAAGATGGGTTTGAGCAG-3'
R-AGTTTCATGAGGAGAACGGAAT-3'

100065275

151

101%

0.984

Versican
αGAG Domain

F-ACACTTCCCATACGGTTTCTCT-3'
R-AGGAGAAATAGTCGCTTCAAGG-3'

100065275

152

108%

1.000

Versican
βGAG Domain

F-GTTTTCAGCACATCTCTTGAGG-3'
R-TTTCTGGTAGCAGATGCTGAAT-3'

100065275

179

101%

0.999

Versican
C17

F-CCTGCAATTACCATCTCACCTA-3'
R-CAGGGAGTTGATTTCATAACGA-3'

100065275

122

92%

0.988

Vimentin

F-ACGTTCGTCAGCAGTATGAAA-3’
R-GTTAGCAGCCTCAGAGAGGTC-3’

100056088

98

97%

0.990
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Wnt4

F-AGCTGGAAAAGTGTGGCTGT-3’
R-GTCCACAAACGACTGTGAGAAG-3’

100071678

110

119

103%

0.970

APPENDIX C
ANTIBODIES UTILIZED IN WESTERN BLOTTING
Primary Antibodies
Epitope
Rabbit Polyclonal to
Human ADAMTS-4
Catalytic Neoepitope
FASLSRFVET
Mouse Monoclonal [BC3] to Human Aggrecan
ARGSVIL
Mouse Monoclonal to βActin
Rabbit Polyclonal to
Human β-Catenin
AA768-781
Mouse Monoclonal
[M168] to Mouse ECadherin
C-terminal region
Rabbit Polyclonal to Rat
GSK3β
AA335-349
Rabbit Monoclonal
[EPR2286Y] to Human
GSK3β serine 9
phosphorylation
Mouse Monoclonal to
Human Integrin β4
AA1612-1821
Rabbit Monoclonal
[EP1247Y] to MMP-1
AA115-140
Rabbit Polyclonal to
MMP-13
AA250-350
Rabbit Polyclonal to
Versican (V0/V1)
ADAMTS-4 Cleavage
Neoepitope DPEAAE

Company

Dilution

Gift of the Tortorella
laboratory (Totorella
et al., 2005)

1:500

AbCam ab3773

1:2,000

AbCam ab8226

1:20,000

AbCam ab6302

1:4,000

AbCam ab76055

1:1,000

Millipore 07-1413

1:500

Millipore 04-1075

1:5,000

Becton Dickinson
611232

1:500

AbCam ab52631

1:1,000

AbCam ab84594

1:1,000

AbCam ab19345

1:2,000
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Rabbit Polyclonal to
Versican (V0/V2)
ADAMTS-4 Cleavage
Neoepitope NIVSFE
Rabbit Polyclonal to
Mouse Versican
AA535-598 (αGAG
Domain, V0/V2)
Rabbit Polyclonal to
Mouse Versican
AA1360-1439 (βGAG
Domain, V1)
Mouse Monoclonal [V9]
to Vimentin

AbCam ab28761

1:2,000

Millipore AB1032

1:1,000

Millipore AB1033

1:1,000

AbCam ab8069

1:1,000

Secondary Antibodies

Epitope

Company

Dilution

Sheep Polyclonal to Mouse IgG(H&L)

AbCam
ab6808

1:10,000

Sheep Polyclonal to Rabbit IgG (H&L)

AbCam
ab6795

1:10,000
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APPENDIX D
ANTIBODIES UTILIZED IN IMMUNOFLUORESCENT LOCALIZATION

Primary Antibodies

Epitope
Rabbit Polyclonal to Human Aggrecan
AA89-106 (G2 domain)
Rabbit Polyclonal to Human β-Catenin
AA768-781
Mouse Monoclonal to Chondroitin-6Sulfate

Company
AbCam ab16320 (no longer
available)

Dilution

AbCam ab6302

1:100

Millipore MAB2035

1:100

Mouse Monoclonal to Collagen I

AbCam ab6308

1:200

Mouse Monoclonal [M168] to Mouse ECadherin C-Terminal Domain

AbCam ab76055

1:100

Rabbit Polyclonal to Fibronectin

AbCam ab2413

1:200

Rabbit Polyclonal to Human Frizzled 4
AA488-537

AbCam ab83024

1:100

Sheep Polyclonal to Hyaluronic Acid

AbCam ab53842

1:250

Mouse Monoclonal to Human Integrin β4
AA1612-1821

Becton Dickinson 611232

1:50

Mouse Monoclonal to Keratan Sulfate

Millipore MAB2022

1:100

Rabbit Polyclonal to Laminin (Panreactive antibody)

AbCam ab11575

1:100

Rabbit Polyclonal to MMP-13 AA250-350

AbCam ab84594

1:100

Goat Polyclonal to Human Versican (T20)

Santa Cruz 26706

1:20

Rabbit Polyclonal to Human Wnt 4

AbCam ab91226

1:50
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1:50

Secondary Antibodies

Epitope

Company

Dilution

Donkey Polyclonal to Goat IgG Rhodamine RedX Conjugate

JacksonImmunoResearch
711-295-147

1:200

Donkey Polyclonal to Mouse IgG AlexaFluor 488 Conjugate

JacksonImmunoResearch
715-545-150

1:200

Donkey Polyclonal to Mouse IgG AlexaFluor 594 Conjugate

JacksonImmunoResearch
715-585-150

1:200

Rabbit Polyclonal to Sheep IgG - Texas
Red Conjugate

AbCam ab6745

1:200

Donkey Polyclonal to Rabbit IgG AlexaFluor 488 Conjugate

JacksonImmunoResearch
711-545-152

1:200

Donkey Polyclonal to Rabbit IgG AlexaFluor 594 Conjugate

JacksonImmunoResearch
711-585-152

1:200
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